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ABSTRACT
Total hip arthroplasty is often renowned as one of the most important surgical
advances of the past century. Orthopaedic surgeons must choose a surgical
approach to gain access to the hip joint in order to perform the reconstruction.
There is debate in the literature as to which surgical approach optimizes patient
outcomes, minimizes complications, and reduces costs to hospitals as a high
volume procedure.
In the current studies, patient reported outcomes were compared at short-term
follow-up using a prospective study design across the anterior, posterior, and
lateral approach. A micro-costing method was used to acquire costs related to
each procedure, as well as compare hospital metrics such as operating room
time and hospital length of stay.
The anterior approach demonstrated superior functional outcomes at short-term
follow-up, and significantly reduced costs from a hospital perspective. Further
studies should compare objective assessments of function such as gait
analysis, and cost-effectiveness from a societal perspective.
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Chapter 1
1

Introduction

This thesis aims to explore the role surgical approach in total hip arthroplasty
has on patient reported outcomes and costs of the procedure from a hospital
perspective. This chapter will review basic anatomy and principles of hip
arthritis and total hip arthroplasty so that the context of the following chapters is
clear. The anatomical and technical considerations for the anterior, posterior,
and lateral approaches to the hip will be reviewed. This will facilitate
understanding how subtle differences between the three approaches may
impact clinical results.

1.1 The Hip
The hip is a ball-and-socket synovial joint formed through an articulation
between the femoral head and the acetabulum of the pelvis. This articulation
permits movement through the coronal, sagittal, and transverse planes 1. A
variety of muscles surround the hip joint, each with their own unique nervous
innervation and action. The hip joint can be accessed surgically through various
inter-nervous planes, as well as intra-muscular dissection 2.

1.1.1 Osteology
The two main bones of the hip include the proximal femur and the bony pelvis.
The pelvis includes the fusion of three separate bony elements to create the
acetabulum (Figure 1.1). Each bone has a unique set of bony prominences that
serve as attachment sites for muscles and ligaments, as well as landmarks for
planning surgical approaches 1, 2.

1

Figure 1.1 – Osteology of proximal femur and pelvis
A diagram demonstrating the main bony constituents of the hip joint and bony
pelvis. The hip joint is represented by the articulation between the femoral head
and acetabulum (S Petis).

2

1.1.1.1

Femur

The proximal femur consists of four main components – head, neck, and the
greater and lesser trochanters 3. The femoral head projects in a superomedial
direction to articulate with the acetabulum 1. The majority of its surface is
covered with articular cartilage, which allows near frictionless and painless
range of motion during daily activities such as gait 4.
The greater trochanter is a bony prominence located laterally and posteriorly on
the proximal femur. The lesser trochanter is a smaller prominence located
posteromedially at the neck-shaft junction 3. They serve as important landmarks
during surgical dissection, as well as attachment sites of numerous muscles
around the hip 1-3.
The neck of the femur forms an angle with the femoral diaphysis of
approximately 130 degrees in the coronal plane (Figure 1.2). Femoral
anteversion refers to the angle formed when the femoral neck axis and the
distal transverse condylar axis are superimposed 1. This angle varies from 8-12
degrees anterior to the distal transverse condylar axis (Figure 1.3) 4. Femoral
retroversion occurs when the femoral neck version is directed posterior to the
transverse condylar axis 1. These angles are important to consider during
reconstructive procedures such as total hip arthroplasty (THA).

1.1.1.2

Acetabulum

The acetabulum is the socket of the hip joint. It is formed by the fusion of the triradiate cartilage, which is the growth plate formed by the bony elements of the
pelvis. These elements include the ischium, ilium, and pubis 1. Approximately
two-fifths of the acetabulum is contributed by the ilium and ischium, with the
pubis comprising the remaining fifth. The acetabulum opens laterally, inferiorly,
and anteriorly 5. The degree of anterior inclination is referred to as acetabular
anteversion, an angle typically measuring 15-23 degrees (Figure 1.3) 6, 7.

3

The rim of the acetabulum serves as an attachment site for the labrum, a fibrocartilaginous structure that deepens the articular surface of the hip joint 5. The
femoral head is also supported within the acetabulum by the transverse
acetabular ligament. This structure supports the most inferior aspect of the
acetabulum, and is a useful landmark for determining acetabular anteversion
during acetabular reconstructions 6.

4

Figure 1.2 – Femoral neck-shaft angle
The angle subtended by α represents the neck-shaft angle of the proximal
femur. This angle is normally 130 degrees in the coronal plane. Other important
bony landmarks such as the greater and lesser trochanters serve as attachment
sites for muscles and ligaments (S Petis).

5

Figure 1.3 – Version of acetabulum and femoral neck
This axial cross-section of the hip joint demonstrates both acetabular and
femoral neck version. Acetabular version, represented by angle α, is an angle
formed by a line along the anterior and posterior aspect of the acetabulum
intersecting a line in the sagittal plane. Normally, the acetabulum opens
anteriorly, as demonstrated in this diagram, which is referred to as anteversion.
If the acetabulum opens posteriorly, this is referred to as retroversion. Normal
acetabular version is 15-23 degrees of anteversion. Femoral neck version,
represented by angle Σ, is an angle formed by a line along the axis of the
femoral neck and the distal transverse condylar axis of the knee. This angle is
normally 8-12 degrees of femoral anteversion (S Petis).
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1.1.2 Musculature around the hip
There are several muscles that surround the hip joint. Each muscle has its own
bony or soft tissue origin and insertion, as well as nervous innervation. The
nervous innervation of each muscle creates inter-nervous planes that are
essential to understand when dissecting around the hip joint 2.

1.1.2.1

Sartorius

The sartorius is the longest muscle in the body. It originates off the anteriorsuperior iliac spine of the pelvis, and inserts on the proximal tibia as part of the
pes anserine group. It is a weak hip flexor and external rotator, as well as a
weak knee flexor and internal rotator 1. It is innervated by the femoral nerve and
serves as an important muscle during superficial dissection when using the
anterior approach to the hip 8.

1.1.2.2

Tensor fascia latae

The tensor fascia latae is a more laterally based muscle originating from the
anterior-superior iliac spine and inserting onto the iliotibial band. It assists in
abduction, flexion, and internal rotation of the hip 1. Innervated by the superior
gluteal nerve, it forms a superficial inter-nervous plane with sartorius during the
anterior approach to the hip 9.

1.1.2.3

Rectus femoris

The rectus femoris is a member of the quadriceps femoris group innervated by
the femoral nerve. It is the only muscle in the group to cross both the hip and
knee joints. This allows the muscle to contribute to flexion at the hip, and
extension at the knee 1. The muscle originates via a direct and indirect head;
the direct head comes off of the anterior-inferior iliac spine, while the indirect
head originates from the superior rim of the acetabulum and the anterior joint
capsule (Figure 1.4) 1, 2. This is important during an anterior approach to the

7

hip, as both the direct and indirect head are retracted to improve visualization of
the femur and acetabulum during reconstructive procedures 9-11.

1.1.2.4

Gluteus medius

The gluteus medius is a large, fan-shaped muscle often referred to as the
“rotator cuff” of the hip 12. It originates from the ilium between the anterior and
posterior gluteal lines, splits into anterior, middle, and posterior portions, and
inserts into two facets on the greater trochanter 1, 13. Each portion of the gluteus
medius is innervated by a branch of the superior gluteal nerve 12. This muscle
initiates hip abduction, produces subtle pelvic rotation to optimize gait
efficiency, and helps stabilize the femoral head within the acetabulum during
weight bearing 12, 14. It is important to understand the anatomic boundaries of
this muscle during a lateral approach to the hip 15.

1.1.2.5

Gluteus maximus

The gluteus maximus is a large muscle originating from the sacrum, ilium, and
thoracolumbar fascia. It has upper and lower fibers inserting on the iliotibial
band and gluteal tuberosity, respectively. This muscle is a powerful hip extensor
and external rotator 1. Innervated by the inferior gluteal nerve, many of the
muscle fibers of gluteus maximus are split during a posterior approach to the
hip 2.

1.1.2.6

Short external rotators

The group of muscles commonly referred to as the short external rotators
includes piriformis, obturator internus, and the superior and inferior gemelli
muscles (Figure 1.5). They originate from various bony landmarks including the
sacrum, ischial spine and tuberosity, and the obturator foramen 1. The gemelli
form a conjoint tendon with obturator internus to insert on the medial aspect of
the greater trochanter, whereas piriformis inserts at the apex of the greater

8

trochanter 1, 2. These muscles receive their nervous innervation from small
branches of the sacral plexus, and they are weak contributors to hip external
rotation. They are important landmarks during the posterior approach to the hip,
and are often used to help identify and protect the sciatic nerve during this
approach 2.

9

Figure 1.4 – Anterior muscles of the hip
There are several important muscles crossing the anterior aspect of the hip
joint. These muscles form important inter-nervous planes that allow the surgeon
to access the hip joint safely. The sartorius and tensor fascia latae form the
superficial inter-nervous plane for an anterior approach to the hip. The rectus
femoris forms the deep inter-nervous plane of the anterior approach with the
gluteus medius. Note the two tendinous insertions of the rectus femoris (S
Petis).
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Figure 1.5 – Posterior muscles of the hip
This diagram depicts many muscles that cross the hip posteriorly and laterally.
The tendinous insertion of the gluteus medius is split during a lateral approach
to the hip. The superior and inferior gemelli and obturator internus form a
conjoint tendon that is dissected off the proximal femur with the piriformis during
a posterior approach to the hip (S Petis).
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1.2 An overview of hip arthritis
The purpose of this section is to provide a brief overview of hip arthritis, its
clinical features, and non-arthroplasty forms of treatment. The discussion will
then describe total hip arthroplasty and its impact on patient outcomes. This will
help demonstrate how the various surgical approaches to the hip can impact
clinical outcomes.

1.2.1 Hip arthritis
Arthritis is a degenerative pathologic condition of the articular cartilage of
synovial joints 16. Damage and loss of articular cartilage leads to 4 cardinal
changes within the joint: joint space narrowing, osteophytosis, subchondral
bony sclerosis, and subchondral cyst formation (Figure 1.6) 17. These changes
cause debilitating musculoskeletal pain and psychological distress to those who
have to live with the disease 18.

12

Figure 1.6 – The normal and arthritic hip joint
The top image is an anterior
anterior-posterior
posterior radiograph of a normal hip joint. The
bottom image is an anterior
anterior-posterior
posterior radiograph of an arthritic hip joint. Note
the cardinal signs of arthritis on the bottom radiograph: joint space narrowing,
osteophyte formation, subchondral sclerosis, and cyst formation (S Petis).
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1.2.1.1

Etiologies

Osteoarthritis is the most common cause of arthritis of the hip joint 16. Primary
osteoarthritis, or idiopathic arthritis, refers to cases where the cause of joint
degeneration is unknown. Cases where there is an identifiable cause for the
degenerative process are referred to as secondary osteoarthritis 19. Several risk
factors have been identified that may contribute to the development of
osteoarthritis. Systemic factors include increased age, female sex and estrogen
deficiency, increased bone density, poor nutrition, and genetics. Biomechanical
risk factors include obesity, previous joint trauma, congenital joint deformities,
certain vocations such as farming, sports participation, and surrounding muscle
weakness 17, 20. Other contributing factors include femoroacetabular
impingement (FAI), developmental hip dysplasia, and slipped capital femoral
epiphysis, although the details of each are beyond the scope of this discussion
16, 21, 22

.

Other causes of joint degeneration within the hip are related to biological
processes causing damage to the hyaline articular cartilage. Generally, these
conditions expedite the degenerative process and cause much earlier
debilitating pain and functional limitations 16. Osteonecrosis of the femoral head,
also known as avascular necrosis, is the result of ischemia to the subchondral
bone, causing collapse of the supportive bony architecture and accelerated
cartilage damage due to altered biomechanical stresses 23. Legg-Calvé-Perthes
disease is the childhood variant of idiopathic femoral head ischemia and
necrosis leading to degenerative changes later in life 24. Inflammatory arthritides
are another cause of hip arthritis, examples of which include rheumatoid
arthritis, ankylosing spondylitis, and systemic lupus erythematosus 16. Joint
destruction results from an aggressive inflammatory process driven by an
autoimmune response to host biomarkers 25. Finally, rapid and profound
articular cartilage destruction is the devastating sequelae of untreated septic
arthritis 26. All of these conditions must be considered when consulting a patient
regarding hip arthritis (Figure 1.7).
14
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Primary Osteoarthritis

-
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Figure 1.7 – Etiologies of hip arthritis
Several different factors contribute to the degenerative changes manifested as
hip arthritis. The most common is primary, or idiopathic osteoarthritis. All other
etiologies should be considered when acquiring a history from a patient with hip
pain (S Petis).
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1.2.1.2

Clinical features of hip arthritis

Patients presenting with hip arthritis will have a number of clinical features
unique to this disease. The patient will often complain of groin pain, buttock
pain, or pain around the greater trochanter 27. The patient will often cup their hip
with their hand when asked to locate the pain, which is known as the “C” sign.
The pain may radiate to the inside of the knee due to irritation of the saphenous
branch of the femoral nerve 28. The pain is usually worse with activity, and
abates with rest. Patients report that activities of daily living such as walking
and self-hygiene have become cumbersome. Other associated symptoms
include stiffness, joint instability, and motor weakness. Careful questioning
should determine that the pain in the hip is not due to radiating patterns from
the spine and knee as well 29.
A detailed physical examination is essential in confirming the diagnosis, and
eliciting findings that may impact future reconstructive procedures 27. Physical
examination should begin by observing the patient’s gait. A Trendelenburg gait
and sign is a common physical finding resulting from abductor weakness 14. The
hip should be fully exposed to examine for bruising, swelling, erythema, or
previous surgical scars. The examiner should note any leg length discrepancy
that may impact future reconstructive procedures 27. Range of motion and
strength testing should document any limitations. Patients with hip arthritis
typically have reduction in internal rotation and abduction, with pain in the groin
elicited with internal rotation 29. Pain produced in the groin with an active
straight leg raise is often associated with hip arthritis, which is known as the
Stinchfield test 30. A complete neurovascular examination is critical to compare
to any potential post-operative changes. Again, examination of the spine and
knee are essential to ensure that the true source of functional limitation and
pain is originating from the hip.
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1.2.1.3

Epidemiology of hip arthritis

Hip arthritis has a tremendous impact on patient quality of life and level of
functioning. By the year 2020, the World Health Organization projects that
osteoarthritis is expected to become the 4th leading contributor to patient
disability 31. A recent systematic review suggests a prevalence of 10.9% for hip
osteoarthritis for all-comers 32. This prevalence differs for different countries
around the world, as well as whether a clinical or radiographic definition is used
to diagnose osteoarthritis 33. Health care systems incur tremendous costs while
patients live with debilitating hip arthritis. This is particularly true when patients
are waiting for joint replacement surgery, a time when health related quality of
life and functionality are presumed to be the lowest 34, 35. As populations
continue to live longer, more people will live with chronic disease such as
arthritis, creating increased demand for both non-surgical and surgical modes of
treatment 33.

1.2.1.4

Treatment of hip arthritis – Non-surgical

There are a variety of non-surgical treatment modalities available to mitigate the
pain associated with arthritis. Treatment of hip arthritis should be tailored to
patients’ symptoms and previous therapies. Initially, treatment should begin with
less invasive options and progress towards surgical intervention 29.
Early non-operative management includes exercise therapy. This has been
shown to reduce pain early following the diagnosis of hip arthritis, and can
contribute to weight-loss and muscle strengthening 36. Weight-loss has been
shown to reduce disability associated with osteoarthritis 37. The use of a gait aid
such as a cane or a walker can help produce an abductor moment to off-load
the affected hip, particularly in the setting of abductor insufficiency. Patients
may also need to avoid activities that exacerbate their hip pain, which
sometimes includes taking time off of work if the individual is employed.
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After these measures have failed, pharmacotherapy can effectively control pain
associated with osteoarthritis. A Cochrane review has demonstrated that
acetaminophen is better than placebo at controlling pain associated with
osteoarthritis. Non-steroidal anti-inflammatory drugs (NSAIDs) may be more
effective than acetaminophen at controlling painful osteoarthritis; however,
there is an increased risk of gastrointestinal side effects, hypertension, and
renal dysfunction with prolonged NSAID use 38. Corticosteroid and viscosupplementation injections are also treatment options 29. These injections are
usually performed under radiographic or ultrasonographic guidance when used
to treat painful osteoarthritis of the hip. Studies have demonstrated reduced
pain and less reliance on other medications such as NSAIDs following viscosupplementation 39, 40.

1.2.1.5

Treatment of hip arthritis – Surgical

There are a number of surgical procedures available to treat patients with
painful hip arthritis once non-surgical methods have become ineffective. Within
the realm of surgical procedures, a number of non-arthroplasty options must be
considered. Total hip arthroplasty will be discussed in greater detail in the
following section.
Hip arthroscopy has become a popular procedure in the setting of the painful
hip. Its utilization has steadily increased over the past decade as both a
diagnostic and therapeutic procedure 41. In the literature, indications include
removal of intra-articular loose bodies, osteochondroplasty for painful
impingement associated with FAI, grading the degree of articular cartilage
degeneration, labral repair, synovectomy, irrigation of septic arthritis, extraarticular tendon releases, and debridement for osteoarthritis 16, 42. However,
there is a paucity of literature documenting the clinical efficacy of hip
arthroscopy in treating pain due to hip arthritis at long-term follow-up. Therefore,
managing patient expectations is very important when considering this surgical
procedure 41.
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Other surgical considerations are used for specific circumstances. The periacetabular osteotomy as described by Ganz can manage painful hip arthritis
and limit the progression of degeneration in patients with mild to moderate
acetabular dysplasia 43. Proximal femoral osteotomies can correct deformities
that create accelerated wear on articular cartilage from increased
biomechanical stresses. Valgus- or varus-producing osteotomies, derotation
osteotomies, and shortening osteotomies are used in conditions such as
developmental dysplasia of the hip, Legg-Calve-Perthes disease, slipped
capital femoral epiphysis, or post-traumatic arthritis 16, 27. Hip arthrodesis, or
fusion, is largely a historical procedure reserved for young patients with severe
hip arthritis in order to delay the need for a reconstructive procedure (Figure
1.8) 16.
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Patient diagnosed with hip arthritis

Non-operative treatment:
- Weight loss
- Exercise
- Activity modification
- Gait aid

Pharmacotherapy:
- Acetaminophen
- NSAIDs
- Injections

Surgical considerations in
young patient or specific
diagnosis (i.e. FAI):
- Hip arthroscopy
- Periacetabular /
femoral osteotomy
- Hip arthrodesis

Failed non-surgical
modalities or other
surgical interventions:
- Total hip
arthroplasty

Figure 1.8 – Treatment algorithm for hip arthritis
This diagram represents a treatment algorithm for hip arthritis. Patients undergo
a trial of non-operative management modalities such as gait aids and
pharmacotherapy. If these fail, the treating surgeon considers surgical
management tailored to each patient’s underlying pathology (S Petis).
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1.2.2

Total hip arthroplasty

Since its inception in the late 1950s, THA has revolutionized the treatment of
painful hip arthritis 44. The main constituents of the surgical reconstruction
include a femoral stem, acetabular shell, and bearing articulation. This section
will briefly outline the technical aspects of the procedure, as well as its clinical
efficacy in the literature.

1.2.2.1

Femoral reconstruction

The goal of THA is to reproduce the native center of rotation of the femoral
head 27. This involves inserting a metal femoral stem into the proximal femur
(Figure 1.9). The reconstruction begins by exposing the proximal femur through
the chosen surgical approach. The femoral head is then dislocated from the
acetabulum in a controlled manner. This will provide the surgeon with
visualization of the femoral head, neck, and greater and lesser trochanters 16, 27.
Once the femoral neck is exposed, an oscillating saw is used to perform an
osteotomy of the femoral neck. The location of this osteotomy is dependent on
careful pre-operative templating 16. Generally, this osteotomy is performed
approximately 1 centimeter above the lesser trochanter, and perpendicular to
the long axis of the femoral neck 45. This will allow the surgeon to prepare the
femoral intramedullary canal to receive the femoral stem implant.
The intramedullary canal is prepared using a series of graded reamers and
broaches. These instruments are passed down the canal, and the broaches are
often used as trial implants to represent the appropriately sized femoral implant.
With the broach in-situ, a trial femoral head is placed on the neck of the femoral
implant and reduced into a reconstructed acetabulum. This is when the surgeon
decides to ask for the definitive implants, or make adjustments based on the
following principles.
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It is important that the surgeon matches the patient’s femoral anteversion while
broaching to prevent instability and impingement associated with an overly
anteverted or retroverted implant 46. The surgeon must be cognizant of the
depth the femoral stem is implanted in order to maintain leg length equality and
tensioning of the surrounding soft tissue including muscles and ligaments 27.
Soft tissue tensioning is also impacted by femoral offset, which is the distance
from the center of the femoral head to the center of the femoral canal 47.
Restoring these anatomic variables will produce more efficient gait mechanics
and limit excess biomechanical stresses across the implant 27.
Finally, the surgeon must then choose whether to use a cemented or
cementless femoral stem. Cemented femoral stems are placed into a 2-4
millimeter polymethylmethacrylate polymer mantle that acts as a grouting
material to interdigitate with the host bone 48, 49. They are generally smooth,
highly polished stems with no sharp edges to limit de-bonding from the cement
mantle 50. This form of fixation has several indications including profound
osteopenia, irradiated bone, and unusual proximal femoral anatomy 27.
Cementless femoral stems rely on biological bony in-growth into a porous
coating or bony on-growth onto a grit-blasted or hydroxyapatite surface 27, 51-53.
They are an attractive option because there is no need to use cement intraoperatively, resulting in shorter surgical times and reducing the theoretical risk
of intra-operative hypotension caused by pressurizing cement into the femoral
canal 54, 55. Regardless of the mode of fixation, many femoral stems have
excellent survivorship and clinical outcomes at long-term follow-up 56-61.
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Figure 1.11 – Femoral stem

Figure 1.9 – Femoral stem
This is an example of the Corail TM stem (DePuy Orthopaedics Inc., Warsaw,
IN), a femoral stem used to reconstruct the proximal femur. It is an example of a
cementless, hydroxyapatite
hydroxyapatite-coated stem (S Petis).
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1.2.2.2

Acetabular reconstruction

Acetabular reconstruction is the second constituent of a THA. As with femoral
reconstructions, the goal of reconstructing the acetabulum is to reproduce the
anatomic center of rotation to enable functional range of motion and stability 16,
62-64

. Pre-operative radiographs are useful in planning the positioning of

acetabular component, as adequate medialization of the component to the
acetabular floor limits biomechanical stresses and early implant failure 64, 65.
In order to ensure proper component positioning, the acetabulum must be
adequately exposed through the chosen surgical approach 16, 27. Surrounding
soft tissue including joint capsule, labrum, and osteophytes are removed from
the rim of the acetabulum. Acetabular reamers are then used to prepare the
floor of the acetabulum to accept the acetabular implant. The size of the reamer
incrementally increases until the size of the last reamer engages the anteriorposterior extent of the native acetabulum 27. Throughout reaming, the surgeon
is able to control the version and inclination of the acetabular reconstruction.
Bony landmarks as well as soft tissue structures are used to assist the surgeon
in reproducing anatomic acetabular anteversion 63, 66, 67. Inclination is re-created
by visualizing the position of the final reamer relative to the floor of the
operating room, as well as a cup positioner or guide that accompanies many
total hip implant systems 68, 69. Acetabular inclination between 35-45 degrees
has been shown to optimize range of motion, limit impingement on the femoral
component, and lower the risk of hip dislocation 63, 70, 71. As with femoral
reconstructions, trial implants are available to allow the surgeon to reduce the
reconstructed hip and assess range of motion and stability before definitive
implant selection 27, 68, 69.
Once the surgeon is satisfied with the trial reconstruction, the definitive
acetabular shell is chosen. Current generation acetabular shells are fabricated
from titanium and are porous coated 16. The porous coating allows biological
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bony in-growth that permits implant fixation. Once the shell is in-situ, several
shell manufacturers allow for the insertion of screws to augment fixation into the
bony pelvis 68, 69. The decision to insert screws is based on the surgeon’s
assessment of the patient’s bone quality and bony contact with the shell, comorbid conditions that may preclude quality bony in-growth such as
inflammatory arthropathy, and osteopenia 72, 73. Current generation acetabular
shells provide reliable long-term fixation and excellent clinical outcomes 74-76.

1.2.2.3

Bearing articulations

Once the femoral and acetabular reconstructions are complete, a bearing
articulation must be chosen. Bearing articulations are composed of a femoral
head, which attaches to the femoral stem via a Morse taper, and an articulating
liner, which sits inside the acetabular shell. There are several options available
when choosing a bearing articulation, each with theoretical advantages and
disadvantages.
The acetabular liner can include polyethylene, ceramic, or metal 16.
Polyethylene is a plastic that is the most utilized lining surface in total hip
arthroplasty 77. The most concerning feature of polyethylene use is wear,
resulting in particulate matter that causes phagocytosis of bone, osteolysis, and
implant loosening 78, 79. Biomedical engineers have constantly modified how
polyethylene is manufactured in order to reduce wear and improve the longevity
of the plastic. This includes sterilization in inert atmospheres such as ethylene
oxide or gas plasma, re-melting versus annealing, and exposing the
polyethylene to radiation 80. Radiation has been shown to induce cross-linking
at the molecular level, which improves the wear resistance of the plastic 81. This
has lead to improved wear resistance in-vivo with at least intermediate follow-up
82-84

.

Metal is another consideration as an acetabular lining material. In simulator
studies, metal has improved wear resistance over polyethylene 85, 86. Metal is
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also less brittle compared to ceramic, reducing the risk of implant fracture 87.
However, studies have demonstrated that metal bearings can increase the
generation of chromium and cobalt ions, which can leach into human serum
and be excreted in urine 88, 89. This may induce a T-cell mediated lymphocytic
reaction referred to as an atypical lymphocytic vasculitis-associated lesion.
These lesions may result in aseptic loosening and failure of metal-on-metal
arthroplasties 90. Pseudotumors are a localized granulomatous reaction to metal
ions that can cause inflammation, pain, and the need for revision surgery for
patients with metal-on-metal articulations 91. Although there are concerns
regarding increased carcinogenesis risk, nephrotoxicity, and neurotoxicity
associated with elevated metal ion levels, these presumptions are poorly
supported in the literature 79, 92, 93.
Ceramic was introduced as an acetabular liner in the 1970s 94. The material has
undergone several generational changes, resulting in a contemporary alumina
composite material 95. The advantages of ceramic materials are that they are
extremely hard and scratch resistant, which amounts to reduced wears rates
compared to other articulating bearings 96-98. Ceramic also exhibits good
biological inertness, reducing localized soft tissue reactivity 99. The main
disadvantages of ceramic materials are the risk of fracture due to increased
brittleness, and squeaking due to edge loading in-situ. The risk of implant
fracture has lessened significantly with the introduction of tougher alumina
composites 94. Edge loading and resultant squeaking are caused by poor
component positioning, inability to restore leg-lengths and femoral offset, and
implant impingement 100, 101. Careful surgical technique can therefore ameliorate
the risk of squeaking.
Once the acetabular liner has been chosen, the surgeon is left to choose a
femoral head to articulate with the liner. Three main femoral head materials
exist: metal, which is usually made from a cobalt chromium alloy, ceramic, and
oxidized zirconium. Cobalt chrome is a long-standing femoral head bearing with
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the advantage of modularity, or availability of different implant specifications
that allow the surgeon to better customize their reconstruction during THA 102.
Ceramic has demonstrated reduced wear rates when compared to cobalt
chrome, both in simulation and clinical studies 103, 104. However, the retained
fragments of a fractured ceramic head can cause accelerated polyethylene
wear, metallosis, and damage to the Morse taper located on the femoral stem
(Figure 1.10) 105, 106. Oxidized zirconium is a newer material composed of a
metallic alloy center and an oxidized zirconium surface. It was designed to
retain the exceptional wear rates seen with ceramic bearing surfaces, but
reduce the risk of implant fracture 94. Early clinical follow-up suggests reduced
wear when compared to cobalt chromium 107. This section clearly outlines the
number of implant options available to the surgeon and the complexities of
choosing the right combination of implants for each individual patient.

27

Figure 1.10 – Assembled femoral stem and head
The femoral head is engaged onto the femoral stem through a Morse taper. The
femoral head is carefully seated on the femoral neck, followed by the surgeon
impacting the head with a mallet to engage the taper (S Petis).
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1.3 Surgical approaches for total hip arthroplasty
There are a variety of surgical approaches available to access the hip joint
when performing a THA. Each approach demands a thorough understanding of
human anatomy in order to optimize femoral and acetabular visualization, and
minimize complications. This section will briefly outline the technical aspects of
the anterior, lateral, and posterior approach, as well as a concise discussion of
associated risks and benefits for each approach. A literature review will outline
how the different approaches may impact patient outcomes and function
following THA.

1.3.1 Anterior approach to the hip
The anterior approach to the hip was first described by Smith-Peterson in the
1940s and was later modified by Heuter in the 1950s 11. In Canada, it is an
approach utilized by less than 5 percent of orthopedic surgeons performing
THA 108. Advocates of this approach identify muscle-sparing intervals, earlier
restoration of gait kinematics, and low dislocation rates as its main advantages
8, 109-112

. The anterior approach can be performed with and without the use of a

specialized table 9, 10. The use of a specialized table will be described in this
section.

1.3.1.1

Anatomy and technical considerations

The procedure begins by positioning the patient supine on a specialized
operating room table (Figure 1.11). Both feet are firmly secured to boots that
are attached to lever arms that permit the application of traction to either limb.
There is also a perineal post located between the legs that stabilizes the patient
on the operating room table, and provides a point of counter-traction 9.
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Figure 1.11 – Anterior approach traction table
An example of a traction table (Hana TM fracture table, Mizuho OSI, Union City,
CA) used for the anterior approach. Both legs are securely fastened in the
boots provided, where traction, rotation, and angular motion can be applied to
both limbs (S Petis).
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The surgical incision begins just lateral to the anterior superior iliac spine of the
pelvis. It is then carried distally for approximately 8 centimeters towards the
patient’s knee (Figure 1.12). The lateral femoral cutaneous nerve is identified,
transposed medially, and protected. A plane is then developed between the
tensor fascia latae and sartorius. The surgeon will then encounter the interval
between rectus femoris and gluteus medius. The rectus femoris is retracted
medially, and the gluteus medius is retracted laterally to expose the anterior
joint capsule of the hip. The joint capsule is then incised along the length of the
femoral neck from the acetabulum to the intertrochanteric line. Once traction is
applied to the operative limb, external rotation can be used to dislocate the
femoral head from the acetabulum 2, 9.
Once the femoral head is dislocated, a femoral neck osteotomy is performed at
the desired level based on pre-operative planning. The femoral neck osteotomy
can also be performed in-situ prior to dislocating the hip with careful soft tissue
retraction. Intra-operative fluoroscopy is used during acetabular reaming to
ensure adequate restoration of anteversion and inclination. Femoral preparation
can be difficult due to limited proximal femoral exposure with this approach. The
operative limb is generally placed in a position of extension, adduction, and
external rotation in order to improve the accessibility of the proximal femur.
Again, intra-operative fluoroscopy is used to help the surgeon determine
accurate preparation of the femoral canal in order to restore version and offset
(Figure 1.13). Once the final implants are in-situ and the hip is reduced, implant
positioning is verified with fluoroscopy and the stability of the construct is
assessed out of traction 2, 9, 10.
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Figure 1.12 – Skin incision for the anterior approach
An intra-operative
operative photograph of the skin incision used for the anterior
approach. The incision starts at the anterior superior iliac spine and heads
towards the lateral aspect of the patient’s knee. A perineal p
post
ost is used to
secure both limbs to the traction table and provide a point of counter-traction
counter
(S
Petis).
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Figure 1.13 – Fluoroscopic C-arm
The fluoroscopic C-arm is a device used to attain x-rays during a surgical
procedure. Many surgeons utilize intra-operative fluoroscopy during an anterior
total hip arthroplasty in order to verify the position of the acetabular and femoral
component (S Petis).
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1.3.1.2

Risks of the anterior approach

There are risks associated with every surgical approach. Commonly cited risks
of the anterior approach include proximal femur fractures, wound complications,
lateral femoral cutaneous nerve palsies, and prolonged operative time due to
the technically demanding nature of the procedure. Jewett and Collis reviewed
800 THAs performed through an anterior approach. They sited 19
intertrochanteric fractures (2.3%), 7 post-operative dislocations (0.88%), and 37
wound complications (4.6%). Most of the intertrochanteric fractures occurred
during preparation of the femoral canal. Wound complications were attributed to
the location of the incision, which is close to the groin area 113.
Another study by Woolson and colleagues retrospectively reviewed 247 THAs
performed through an anterior approach in a community hospital. In 6.5% of
cases there was an intra-operative proximal femur fracture. They also reported
that 21% of cases had acetabular inclination angles greater than 50 degrees
despite the use of intra-operative fluoroscopy 114. This study, as well as results
reported in a small series by Spaans et al., suggests longer operative time and
increased blood loss associated with the anterior approach 114, 115. However,
these findings are likely related to surgeon experience, as Matta et al. reported
much shorter operative time and less blood loss in 437 patients having an
anterior approach 8.
Finally, neurpraxia of the lateral femoral cutaneous nerve can occur in up to
67% of patients having a THA through an anterior approach 116. This is due to
the nerve’s variable course around the anterior superior iliac spine, and as it
crosses the sartorial-tensor fascia latae plane more distally 2, 8. Most of these
neuropraxic injuries resolve without any long-term sequelae 8, 111.
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1.3.2 Lateral approach to the hip
The lateral approach to the hip was described by Hardinge in the 1980s 15.
Approximately 60% of Canadian orthopedic surgeons perform THAs using a
lateral approach 108. This approach provides excellent exposure of both the
proximal femur and acetabulum during reconstructive procedures 2. A very low
dislocation rate has also been reported in clinical follow-up 117, 118.

1.3.2.1

Anatomy and technical considerations

The procedure begins by positioning the patient in either the left of right lateral
decubitus position for a right or left THA, respectively. The operative limb is
draped freely to assist with dislocating the hip in order to expose the proximal
femur and acetabulum. A longitudinal incision is made extending 3-5
centimeters proximal and approximately 5-8 centimeters distal to the tip of the
greater trochanter (Figure 1.14). The fascia of the tensor fascia latae and
gluteus maximus is then split in line with the skin incision. The surgeon will then
encounter the tendon and muscle fibers of gluteus medius. These muscle fibers
are split at the midway point between the most anterior and posterior extent of
the muscle. The split is carried distally, leaving a cuff of gluteus medius tendon
for repair following the procedure. The surgeon then incises the gluteus
minimus and joint capsule overlying the neck of the femur. At this point, the
surgeon is then able to dislocate the femoral head by externally rotating and
flexing the hip. With the hip joint dislocated, the surgeon then performs a
femoral neck osteotomy. This will provide the required exposure to complete
both the femoral and acetabular reconstructions 2, 15.
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Figure 1.14 – Skin incision for the lateral approach
An intra-operative photograph of the skin incision used for the lateral approach.
The patient is positioned in the left lateral decubitus position in preparation for a
right total hip arthroplasty (S Petis).
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1.3.2.2

Risks of the lateral approach

As with the anterior approach, the lateral approach has its own associated risks.
These include abductor muscle insufficiency and a nerve palsy of the superior
gluteal nerve or femoral nerve.
Abductor muscle insufficiency is a common clinical scenario following a lateral
approach. It can cause abductor muscle weakness, a Trendelenburg gait or
sign, inefficient gait mechanics, and peritrochanteric pain 14, 117, 119, 120. The
insufficiency likely results from an inadequate repair following a lateral
approach, chronic degeneration of the gluteus medius tendon pre-operatively,
or irreparable tears at the time of THA in up to 20% of patients undergoing THA
121, 122

. Masonis and Bourne reviewed over 2400 THAs having a lateral

approach for THA and reported an incidence of 4-20% for abductor insufficiency
post-operatively 117.
A superior gluteal or femoral nerve palsy is another potential complication
following a lateral approach to the hip. The superior gluteal nerve passes
between the gluteus medius and minimus muscles approximately 5 centimeters
proximal to the greater trochanter 2. Retrospective and prospective studies
suggest an incidence of 2.2-42.5% for superior gluteal nerve injuries following
reconstructive hip procedures using a lateral approach 123-125. This nerve palsy
can lead to abductor insufficiency and poorer functional outcomes following
THA; fortunately, many cases improve spontaneously 125. The femoral nerve is
at risk with over-rigorous placement of soft tissue retractors over the anterior
aspect of the acetabulum 2. A study by Mulliken et al. did not identify any
femoral nerve injuries in 770 consecutive lateral approaches to the hip 126. The
highest reported rate of femoral nerve palsy using a direct lateral approach was
by Simmons and colleagues. They had 10 palsies in 440 hips with all cases
having full functional recovery at 1 year post-operatively 127.
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1.3.3 Posterior approach to the hip
The posterior approach to the hip was popularized by Moore in the 1950s 2. A
recent survey of surgeons from around the world suggests that the posterior
approach is the most common surgical approach for THA internationally 128. In
Canada, approximately 36% of arthroplasty surgeons utilize the posterior
approach 108. It provides excellent visualization of both the acetabulum and
femur during both primary and revision reconstructive procedures. The
approach also spares the abductor muscles during surgical exposure of the
acetabulum and femur 2.

1.3.3.1

Anatomy and technical considerations

Similar to the lateral approach, the patient is usually placed in the left or right
lateral decubitus position. Again, the involved limb is draped freely to facilitate
dislocating the hip, and to permit maneuverability of the limb to improve
visualization throughout the case. The skin incision begins approximately 6
centimeters proximal and slightly posterior to the posterior aspect of the greater
trochanter. The incision curves towards the greater trochanter and then extends
down the femoral diaphysis for another 5 centimeters (Figure 1.15). The
surgeon then incises the fascia overlying gluteus maximus and bluntly splits this
bulk of muscle down to the short external rotators. The sciatic nerve is often
draped over the short external rotators encased in adipose tissue. This
structure must be carefully protected throughout this approach. The short
external rotators and piriformis are then dissected off their insertion onto the
greater trochanter. This will then expose the posterior joint capsule, which is
incised to reveal the femoral neck and head. The surgeon is then able to
dislocate the hip and begin the reconstruction 2.
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Figure 1.15 – Skin incision for the posterior approach
An intra-operative photograph of the skin incision used for the posterior
approach to the hip. The patient is positioned in the lateral decubitus position.
The incision curves posteriorly proximal to the greater trochanter. Alternatively,
the incision can be made longitudinally with the hip flexed to 90 degrees (S
Petis).
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1.3.3.2

Risks of the posterior approach

A unique risk profile also exists for the posterior approach. Post-operative
dislocations of the hip joint are a concern due to disruption of the posterior joint
capsule 129. By virtue of its proximity to the short external rotators, the sciatic
nerve is vulnerable to injury during this approach 2. These are the most
commonly feared complications of the posterior approach.
The rate of hip dislocations following THA has been extensively studied. In the
literature, reported dislocation rates vary anywhere between 1-5% 118, 130-133.
The reason for the increased incidence of dislocation is because when the hip
is in a functional position of hip flexion and internal rotation, there is
considerable tension on the posterior joint capsule of the hip. The femoral head
then has a propensity to dislocate with inadequate repair of the posterior soft
tissues 2, 118, 129. Kwon et al. performed a meta-analysis to determine the rate of
dislocations using a posterior approach with and without posterior soft tissue
repair and found an 8 times greater relative risk of dislocation when soft tissue
repair was not performed 118. This finding is supported by a recent study by Ho
and colleagues, who also determined that larger femoral head diameter also
reduces the risk of hip dislocation in THA with a posterior approach 132. This is
because larger femoral heads have an increased jump distance, or the distance
the component must travel before it dislocates over the rim of the acetabulum
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. Using a larger femoral head diameter is a commonly cited preventative

measure in patients at risk of dislocation following THA 134-136.
The sciatic nerve is a structure at risk of injury during the posterior approach. It
can be damaged during soft tissue dissection, traction on the extremity, or
during repair of soft tissues during closure 2, 137, 138. A classic study by
Schmalzried et al. reviewed over 3000 THAs and found an isolated sciatic
nerve palsy incidence of 1.3% 139. In most cases, sensory or motor deficits
resolve spontaneously. However, preserving the integrity of the nerve in order
to optimize patient outcomes following THA cannot be understated 138.
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Chapter 2
2

Literature Review

Chapter 1 introduced hip arthritis, the myriad of treatments available to treat the
condition, and an overview of total hip arthroplasty (THA). It also discussed the
three main surgical approaches used to perform a THA. The purpose of this
literature review is to compare clinical performance in patients having a hip
replacement through an anterior, posterior, or lateral approach. A discussion of
economic analyses in the field of medicine and the economic impact of THA on
health care systems will ensue. Finally, the impact of surgical approach on
health economics and the paucity of literature in the setting of THA will be
reviewed.

2.1 Comparing surgical approaches in total hip
arthroplasty
There is a great debate in orthopedic surgery as to which surgical approach to
the hip will produce the best clinical outcomes following a THA. Several studies
have compared the different approaches using various methodologies.
Currently, proponents of muscle-sparing approaches such as the anterior
approach claim that using this approach will reduce post-operative pain, lower
peri-operative blood loss, restore function sooner, and reduce length of stay in
hospital 1. This section will outline the literature to support or dispel these claims
following a brief overview of the different outcome measures used to compare
the approaches.

2.1.1 Clinical outcome questionnaires
There are a multitude of outcome questionnaires available to assess pain,
mobility, level of functioning, and radiographic features associated with hip
arthritis 2, 3. These questionnaires are often scoring systems that allow
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physicians to objectively track patients’ responses to surgical intervention such
as THA 4. The Harris Hip Score (HHS), Western Ontario and McMaster
University Osteoarthritis Index (WOMAC), Short-Form 12 (SF-12), and EQ-5D
questionnaires are common examples 5-8. Ideally, these questionnaires assess
disease-specific and overall aspects of the patient’s health with proven validity,
reliability, and responsiveness to clinical change (Figure 2.1) 3, 9, 10.

Reliable

Feasible administration

Ideal clinical
questionnaire

Responsive to clinical
change

Proven validity

Figure 2.1 – Traits of an ideal clinical questionnaire
Reliability, validity, responsiveness, and the ability to administer a questionnaire
in a timely manner with minimal costs are all considered when choosing a
questionnaire for research purposes (S Petis).
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2.1.1.1

Assessing clinical outcome questionnaires

There are several different characteristics used to describe outcome measures
and assess their utility in determining patient outcomes. Questionnaires may be
disease-specific, where the questionnaire explores specific complaints about a
particular disease process, or generic, which are applicable to any intervention
or disease and capture information about physical, social, emotional, and
mental functioning. Disease processes such as hip arthritis can impact the
elements assessed in generic scales, thus disease-specific and generic
questionnaires are often employed together to determine a patient’s response
to an intervention 9, 11.
Validity is a crucial criterion of a useful outcome questionnaire. Valid
questionnaires are those that measure what they intended to measure 9. The
COSMIN initiative (COnsensus-based Standards for the selection of health
Measurement INstruments) concisely outlines the various domains within
validity 10. Content validity assesses the relevance of each item in a
questionnaire and how well it addresses the constructs, or abstract variables of
a questionnaire. Also important is criterion validity, which correlates the
outcome score with a supposed “gold standard” assessment tool for a given
condition 12. An invalidated questionnaire will not be useful in determining
patient’s responses to an intervention in a specific patient population 3.
An applicable outcome questionnaire in clinical research should also be
reliable. Reliability reflects a scale’s ability to reproduce similar results when
administered on more than one occasion 9. There are several dimensions to
reliability. Internal consistency refers to the redundancy of items in a
questionnaire when assessing different constructs. Inter-rater reliability refers to
achieving similar results on a questionnaire when administered by different
people. Intra-rater reliability refers to getting similar results when either the
same person is administering the test over and over, or is being completed by
the same person on a different occasion. Test-retest reliability measures how
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stable outcomes are on a given questionnaire when tests are repeated after a
short amount of time has elapsed 13. Reliability is subject to measurement error,
which can influence the true variability between patients completing an outcome
questionnaire 14. Using the standard error of measurement (SEM), the smallest
detectable change (SDC) can be calculated. The SDC refers to a real change in
the score not due to error in response to an intervention 15.
Another important consideration when choosing a questionnaire is how well it
will detect important changes following some intervention, a term called
responsiveness 11. Generally, disease-specific scales are more responsive than
generic scales 16-19. This also relates to the minimal important difference (MID),
which is the smallest difference in scores on an outcome questionnaire that the
patient would perceive as important 20. The MID can influence a clinician’s
decision to embrace or abandon a particular intervention 9. Generally, the SDC
should be less than the MID for this to be the case 15.
Finally, floor or ceiling effects are also considerations when choosing a
questionnaire to measure health-related changes to an intervention. These
phenomena occur if greater than 15% of respondents to a questionnaire attain
the lowest (floor) or highest (ceiling) score. This suggests that the questionnaire
may be missing items that assess the absolute best or worst possible clinical
scenario or state of health 15. All of the aforementioned qualities of a healthrelated outcome questionnaire should be considered when choosing which
ones to include as part of a clinical research trial.

2.1.1.2

Harris hip score

The HHS was developed in the 1960s and was designed to assess pain and
function in those individuals living with hip pathology, and to objectively
ascertain their response to treatment 5. It is a score out of 100, with pain (44
points) and function (47 points) receiving the highest contribution to the overall
score. A high score represents a positive outcome. The functional scores
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assess daily activities, as well as the individual’s gait. The remaining points are
culminated by range of motion and the presence or absence of a fixed hip
deformity. It was originally tested and validated in 39 patients undergoing hip
arthroplasty for post-traumatic arthritis 21.
The HHS is an example of a disease-specific outcome measure. The
questionnaire must be completed by a health professional as it includes
objective assessments such as range of motion, deformity, and gait 3. Since its
inception in the 1960s, it is one of the most widely utilized outcome
questionnaires in patients undergoing THA. Soderman and Malchau
demonstrated that the HHS was a valid and reliable measure in a cohort of 344
patients who underwent THA 22. Shi and colleagues showed that the HHS was
more responsive to post-operative changes in pain and function following a
THA than a generic questionnaire, particularly within the first year 23. However,
it should be noted that the HHS does not account for patient characteristics that
may impact some of the scores (i.e. a patient with severe cardiorespiratory
disease and their walking tolerance) 3. As well, a systematic review suggests
that the HHS may succumb to ceiling effects in younger patient populations
undergoing THA such as those with a primary diagnosis of acetabular or
femoral dysplasia 24.

2.1.1.3

Western Ontario and McMaster University Osteoarthritis
Index

The WOMAC is another example of a disease-specific questionnaire.
Developed in the 1980s, the questionnaire is completed by the patient and
includes 24 questions to assess pain, stiffness, and physical function
associated with hip arthritis 6. Each question is assigned 0 to 4 points
depending on the patient’s response, and is then normalized to a score out of
100 3. Again, a higher score is a positive outcome. In the literature, it is a
validated and reliable measure of assessing the response to intervention in
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patients with hip arthritis 6, 25-27. A change score following an intervention of 9-12
points on the WOMAC is considered a MID 25.

2.1.1.4

Short-Form 12

The SF-12 questionnaire was derived from the Medical Outcomes Study 36item Short-Form Health Survey (SF-36) 28. The SF-36 is a validated and reliable
generic health outcome questionnaire that assesses both physical and mental
aspects of health through a Physical Component Summary (PCS) and Mental
Component Summary (MCS) score, respectively 29. The PCS and MCS are
further broken down into 4 domains each. The goal of designing the SF-12 was
to produce a self-administered health survey that was reliable, valid, could be
published on a single page, and took less time to complete than the SF-36 28.
The derivation of the SF-12 healthy survey occurred in the mid-1990s. Ware Jr.
et al. chose 12 items from the SF-36 health survey to represent the PCS and
MCS scores in the SF-12 survey. They found that the items selected were
reliable predictors of the SF-36 scores in a United States population 28. The
survey has now been validated in several other countries around the world 30. A
change score of 3-5 points on the SF-12 is considered a MID 31. It has become
an important measure of health-related quality of life in joint replacement trials,
as both the PCS and MCS scores are impacted substantially by hip arthritis 32,
33

.

2.1.1.5

EQ-5D

The EQ-5D is another example of a generic health outcome questionnaire.
Devised by the EuroQol Group in the 1980s, the EQ-5D consists of 5 questions
and a visual analogue scale to assess health related quality of life. The 5
questions assess mobility, self-care, usual activities, pain, and
anxiety/depression using three degrees of severity (no problems, some
problems, severe problems). Each response is assigned a level from 1 to 3 for
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each question (level 1 = no problems, level 2 = some problems, level 3 = severe
problems), creating a unique 5-digit health state. Therefore, there are 243
possible health states generated by using this questionnaire 8.
Once the 5-digit state has been determined, a summary index can be
calculated. Each level is assigned a weighted value that has been determined
from valuation studies in a given population 8. This valuation is based on utility
theory, where members of a population will have preferences regarding
particular states of health. These preferences were weighted using a timetradeoff method. During valuation of the ED-5D, community respondents were
asked whether they would spend more time in a less desirable state of health
followed by death, or less time in a more desirable state of health followed by
death. The 5-digit state can then be used to calculate the summary index
between -1 and 1, where 1 is perfect health, 0 is death, and any negative value
is a state considered worse than death 13. This index is useful in that it can be
used to calculate Quality Adjusted Life Years (QALYs) in economic
evaluations3.
The EQ-5D has proven to be a valid and reliable measure in assessing quality
of life adjustment following THA 34, 35. A MID of 0.074 has been reported for the
EQ-5D questionnaire 36. A valuation study has been completed in Canada,
providing useful information for determining summary indices in Canadian study
populations 37.

2.1.2 The lateral versus posterior approach
The lateral and posterior approaches are fundamentally similar in that they are
both muscle-splitting approaches to the hip 38. However, as illustrated earlier,
the surrounding anatomy and potential complications for each approach are
much different. Therefore, it is worthwhile to review the literature to determine
whether these differences influence patient outcomes.
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A common discriminative endpoint used to determine the clinical effectiveness
between the lateral and posterior approach is dislocation rate. Intuitively,
patients are more satisfied with surgery and experience better quality of life if
they do not experience a post-operative dislocation 39, 40. After compiling studies
that examined dislocation rate and surgical approach, a systematic review by
Masonis and Bourne demonstrated a dislocation rate of 3.23% and 0.55% for
the posterior and lateral approaches, respectively 41. A review of over 78,000
THAs performed in Sweden suggested a slightly higher dislocation rate when
hip replacements were performed through a posterior approach 42. Conversely,
a Cochrane Review in 2006 identified no difference in dislocation rate between
the two approaches 43. Another comprehensive review by Kwon et al. showed
that with a careful soft tissue repair of the posterior joint capsule, the posterior
approach has a similar dislocation rate to the lateral approach (0.49% vs.
0.43%) 44. The literature suggests that with careful soft tissue closure and
utilization of larger diameter femoral heads, the dislocation rate is similar
between the two approaches 45-47.
Another common comparator between the posterior and lateral approach is the
incidence of abductor insufficiency. Several studies have suggested the lateral
approach has an increased incidence of abductor insufficiency following THA 41,
43, 48, 49

. However, there is tremendous heterogeneity in the methods used to

diagnosis abductor insufficiency in many of these studies. Many studies use
subjective findings to make the diagnosis, such as the presence of
Trendelenburg gait or sign or lateral trochanteric pain, which may suffer from
poor inter-rater reliability. Magnetic resonance imaging (MRI) is becoming a
popular modality for assessing soft tissue pathology following THA 50-53. Several
studies have shown that metal suppression pulsed MRI sequences can identify
abductor damage in patients with symptomatic abductor tears following THA 5254

. Future prospective studies using MRI to assess soft tissue integrity post-

operatively will provide a more objective measure of the incidence of abductor
tears and clinical insufficiency.
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The most important determinants of a successful THA are based on its
indications: pain mitigation, improved quality of life, and restoration of function 1.
These measures are inferred by the use of the aforementioned questionnaires
in clinical trials. An early study by Barber et al. prospectively followed 28
posterior and 21 lateral THAs for 2-years, each performed by a single surgeon.
It should be noted the posterior joint capsule and short external rotators were
not repaired in the THAs performed through the posterior approach. Both
groups had similar improvements on the HHS at 2-year follow-up and had no
observable differences in dislocations or the incidence of a Trendelenburg gait.
The authors suggest that with meticulous surgical dissection, both the lateral
and posterior approaches produce a THA with excellent patient outcomes and
minimal sequelae at intermediate follow-up 55.
A more recent prospective study randomly assigned 60 patients to undergo a
THA through either a posterior or lateral approach. Their primary end-point was
the HHS at 12-week follow-up. They also captured data from the WOMAC and
SF-36 questionnaires, as well as complications such as dislocations and periprosthetic fractures. Both approaches showed similar improvements across the
HHS, WOMAC, and SF-36 questionnaires at multiple time points up to and
including 12-weeks post-operatively. The rate of dislocation and fracture did not
differ significantly between the groups 48.
There are surprisingly few clinical trials directly comparing clinical outcomes
following THA using either of these two approaches 43. The current study will
compare these two approaches and add valuable patient reported outcome
data to the literature.

2.1.3 The anterior versus lateral approach
The anterior approach is the preferred surgical approach of 10% of orthopedic
surgeons performing THA 56. Reduced blood loss, earlier functional recovery,
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low dislocation rates, and shorter stays in hospital have been attributed to the
muscle-sparing properties of the anterior approach 57. Current literature also
suggests that minimizing muscle damage during surgery is a reason for patients
to choose particular surgeons performing muscle-sparing techniques 58. Thus,
several recent studies have compared the anterior approach to both the lateral
and posterior approaches.
From 2006 to 2009, Alecci et al. retrospectively reviewed peri- and intraoperative outcomes of THAs performed through either a lateral (n=198) or
anterior (n=221) approach. Mean operative time was 8 minutes longer in the
anterior group, which was a statistically significant difference between the
groups. The lateral group observed increased peri-operative blood loss and
increased number of blood transfusions compared to the anterior group.
However, the pre-operative hemoglobin was lower in the lateral group, and they
received significantly more fluid throughout each procedure, which may have
contributed to hemo-dilution. Finally, length of stay in hospital was reduced
significantly from 10 to 7 days when a THA was performed through an anterior
approach 59.
A similar study by Restrepo et al. randomly assigned 100 patients to either the
anterior or lateral approach before undergoing a THA. Interestingly, they found
no significant differences in operative time, blood loss, need for blood
transfusions, and length of stay in hospital between the two groups. The
authors also examined patient outcome measures. The anterior group
outperformed the lateral group for the HHS, SF-36, and WOMAC
questionnaires at 6-weeks post-operatively. However, these significant
differences in clinical outcomes abated when revisited at 2-years postoperatively 60. This study suggests that the anterior approach may promote
earlier patient satisfaction and restoration of function compared to a lateral
approach cohort.
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Earlier discharge from hospital using an anterior approach may be due to better
pain mitigation following surgery. Goebel et al. retrospectively reviewed pain
perception using a visual analogue scale (VAS), consumption of pain
medication, and length of stay in hospital in 200 patients having either an
anterior or lateral approach for THA. There was a significant reduction in
perceived pain and consumption of pain medication in the anterior group during
the first 24 hours post-operatively. The anterior group spent approximately 3
days less in hospital as well. Again, improved pain mitigation and earlier
discharge were attributed to the muscle-sparing properties of the anterior
approach 61. However, the accuracy of this data is limited by the retrospective
study design, as well as pain assessment using a VAS and multiple assessors.
There may be an anatomic aberrancy that can explain the discrepancy in
perceived pain between the groups. Bremer et al. performed a MRI 1-year postoperatively in 50 patients having a THA through either an anterior or lateral
approach. They noted significant increases in the number of abductor tears or
detachments, greater trochanteric fluid collections, gluteus medius tendinosis,
and fatty atrophy of the abductor muscles in the lateral group 62. The abductor
complex is a pain generator following the lateral approach and may explain
differences in early pain perception between the groups 63. However, a
limitation of this study includes the absence of clinical outcome measures
assessment. A pre-operative MRI was not performed, which could have
identified patients with evidence of abductor pathology prior to THA, a common
finding in patients with hip arthritis 64. Future research should compare clinical
outcomes and findings on advanced imaging modalities to explain
discrepancies in pain and functional outcomes.

2.1.4 The anterior versus posterior approach
Several studies have also compared the anterior and posterior approaches
using various outcomes. Length of stay in hospital, operative time, and clinical
questionnaire scores such as the HHS are some examples of comparative
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outcomes. Recent literature has also examined the degree of muscle damage
bestowed by each approach.
A prospective randomized trial by Barrett et al. compared 43 anterior and 44
posterior approaches to THA. The primary end-point was the ability to climb
stairs and walk unlimited distances as assessed on the HHS at 6-weeks, 3months, 6-months, and 12-months post-operatively. The authors also captured
intra-operative data including total operative time, and post-operative data such
as length of stay in hospital. Total operative time was 23.8 minutes longer in the
anterior group (p<0.05). Length of stay in hospital was 2.28 days for the anterior
group and 3.02 days for the posterior group (p<0.05). At the 6-week follow-up
visit, significantly more patients were walking limitlessly, were able to climb
stairs normally, and had a higher total HHS in the anterior group. These
differences dissipated by the 3-month mark and remained insignificant up to
and including 1-year post-operatively 65. This study supports the claim that the
anterior approach provides earlier restoration of function following THA.
Again, one of the purported benefits of the earlier functional return is earlier
discharge from hospital. Martin et al. retrospectively reviewed 41 anterior and
47 posterior approaches for THA. Hospital length of stay was significantly
shorter for the anterior group (2.9 versus 4.0 days). Mean operative time was
significantly longer in the anterior approach cohort (141 versus 114 minutes).
Both groups performed similarly on the SF-36 and WOMAC clinical outcome
measures at 6-month follow-up. This study did suffer from selection bias, as the
mean body mass index (BMI = kg/m2) was significantly higher for the posterior
approach group (34.1 versus 28.5 kg/m2). The authors stated that many
patients with obesity declined having an anterior approach when the surgeons
conveyed that the procedure was more technically demanding in patients with a
higher BMI. Anecdotally, patients with obesity do require more assistance with
early mobilization, which may have explained the difference in length of stay
between the groups 66.

66

There is considerable interest in the amount of muscle damage sustained
during surgical approaches to the hip. An interesting study by Bergin et al.
compared various blood markers indicative of muscle damage in patients
undergoing a THA through either an anterior or posterior approach. This
methodology has been used previously to justify the use of tissue-sparing
techniques such as laparoscopy in other surgical subspecialties 67, 68. The
investigators measured pre- and post-operative values of various acute phase
reactant proteins such as creatine kinase (CK), C-reactive protein, interleukin-6,
tumor necrosis factor-alpha, and interleukin-1 in 57 patients undergoing THA.
They found a significant rise in CK in the posterior approach group compared to
the anterior approach group immediately following the procedure, as well as
cumulatively after two days following THA. The other acute phase reactants did
not change significantly between the groups 69. However, the operative time in
the posterior approach cohort was longer, with a mean of 118 minutes versus
78 minutes for the anterior group. A more prolonged period of immobilization on
the operating room table could have contributed to accumulation of additional
serum CK 70. Serum CK clearance is also dependent on renal function, which
was not accounted for in this study 71.
Another study examined the extent of gluteus medius/minimus, tensor fascia
latae, rectus femoris, and short external rotator muscle damage in THAs
performed on 12 cadaveric hips (6 anterior and 6 posterior approaches). Three
different evaluators assessed the surface area of muscle damage from fixed
bony landmarks. Minimal damage was sustained to the gluteus medius muscle
through both approaches. The posterior approach caused more damage to the
gluteus minimus muscle than the anterior approach (18% versus 8.5% of the
mean surface area). The short external rotators were released in all posterior
approach specimens and were damaged in 50% of the anterior approach
specimens in order to improve visualization of the proximal femur. Using an
anterior approach, 31% and 12% of the mean surface area of the tensor fascia
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latae and rectus femoris muscles, respectively, was damaged. No damage to
either of these muscles was sustained using a posterior approach 72. This study
is limited by its use of cadaveric specimens, which would respond differently to
physiologic loads during surgery in-vivo. As well, muscles are 3-dimensional
structures, thus volume would have been a more accurate parameter of
assessing muscle damage. This study challenges the claim that the anterior
approach is truly a muscle-sparing approach. Future studies using gait analysis
could elicit the clinical effects of this muscle damage.
This review has demonstrated that all three surgical approaches allow surgeons
to perform a clinically effective THA procedure. The next step is to evaluate the
cost of surgical interventions such as THA. It is important that surgical
procedures be rigorously reviewed to determine whether the cost of treating
each patient results in a justifiable accentuation of patient function and quality of
life.
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2.2 Health economics and total hip arthroplasty
Despite its technical and tribological intricacies, THA is often heralded as one of
the most successful surgical interventions in medicine 4. In 2005, approximately
21.4 million Americans were living with osteoarthritis. In 2030, that number is
expected to rise to 41 million, largely attributable to improved management of
chronic diseases and prolonged life 73. Thus, the burden of hip arthritis may
overwhelm the available resources within healthcare systems.
Therefore, it is important for physicians, patients, hospital administrators, and
society at large to understand the costs of these procedures. Implants and
surgical approaches used for THA are subject to new innovation, potentially
resulting in increasing costs 74. There are pressures to produce the best clinical
outcome, while remaining cognizant of the costs associated with any
intervention 13. Total hip arthroplasty has been subjected to numerous cost
analyses 75-80. However, none of these analyses suggest whether surgical
approach has a significant impact on health care costs. The purpose of this
section is to provide a concise overview of cost-analysis and its use in THA.

2.2.1 Types of cost analyses in medicine
A variety of methods exist to evaluate the costs associated with medical
interventions. These include cost-minimization/identification analysis, costconsequence analysis, cost-benefit analysis, and cost-effectiveness analysis.

2.2.1.1

Cost-minimization analysis

Cost-minimization analysis is a type of cost-analysis. These analyses are useful
when decisions are solely based on costs because the effectiveness between a
new or experimental treatment is presumed to be equal to the comparator 13.
Therefore, cost-minimization analysis seeks to identify the cheapest means of
attaining similar health outcomes across a treatment and its alternative 81.
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2.2.1.2

Cost-consequence analysis

Cost-consequence analysis disseminates all costs and all outcomes associated
with interventions and do not combine these parameters into a ratio 82. Costconsequence analysis expects a consumer to make value judgments on a list of
costs and outcomes associated with an intervention and an alternative. Simply
stated, the interpreter of the analysis creates their own list of pros and cons in
order to choose the intervention that best suits their needs 13. One advantage of
this type of analysis is how the information can be presented to its users. The
results of the study are often presented in a table format rather than ratios
commonly cited in cost-analysis, which may increase the accessibility of the
information 82.

2.2.1.3

Cost-benefit analysis

A cost-benefit analysis involves expressing both the costs and health outcomes
associated with an intervention in dollars. The outcome measures are assigned
a dollar value by using a willingness to pay value, which is usually inferred from
surveys. This is one of the disadvantages of using a cost-benefit approach, as
people often find it difficult to assign dollar values to intangibles such as health.
If the health benefits valued in dollars less the cost of the intervention is
positive, than that intervention is considered worthwhile. The cost information
required to perform a cost-effectiveness analysis can also be used for costbenefit analyses 13.

2.2.1.4

Cost-effectiveness analysis

At its roots, cost-effectiveness analysis relates the costs accrued during an
intervention to health outcomes in the form an incremental cost-effectiveness
ratio (ICER). This ratio can be generated and compared across various
alternative forms of treatment to determine the lowest cost to achieve a desired
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health outcome. The ICER can also be used to compare interventions across
different disease states to help payers determine which interventions are the
least costly, yet achieve a desired health outcome (i.e. costs of statin therapy
versus total hip arthroplasty in attaining QALYs) 13. Incremental costeffectiveness is different than marginal cost-effectiveness. Marginal costeffectiveness disseminates the costs within a single intervention, such as the
cost of adding or removing a day in hospital 83. Several considerations need to
be taken when designing any cost-analysis study.

2.2.1.5

Importance of perspective

When designing a study examining costs, it is imperative to understand how the
target audience will use the information to facilitate decision-making regarding a
particular intervention. The literature suggests that a societal perspective should
be used when conducting a cost-analysis study in order to influence resource
allocation 84. This perspective ensures that any event that may affect a patient’s
health is included as either a cost or effect 84. The societal perspective ensures
that the cost-analysis captures many events that are apart of routine care, such
as rehabilitation, educational programs, and other patient expenses. Other
common perspectives include those of hospitals or clinics, insurance
companies, and patients 13.

2.2.1.6

Setting boundaries

A term closely associated with perspective is the boundary imparted by the
cost-analysis. Boundaries simply refer to the scope of patients and health
outcomes that will be included, or excluded, in the analysis. In order for the
analysis to exemplify society, a well-designed cost-analysis often has few
exclusion criteria. Developing a cost-analysis with few exclusion criteria will
capture various people living with the disease, living within the spectrum of that
disease, and the individuals impacted by caring for an afflicted individual. The
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health outcome can be non-specific, such as life-years gained, or focus on
constituents of health, such as physical pain, mental status, or functionality 13.

2.2.1.7

Determining the costs

There are a multitude of costs that should be compiled during a cost-analysis.
Ideally, the data on cost is accumulated in a prospective study; however, many
studies retrospectively retrieve data from databases. It is not uncommon for
investigators to add a cost-analysis to an ongoing randomized-controlled trial
(RCT), which is referred to as piggybacking. Although piggybacking may
conduct a cost-analysis in a time efficient manner, the RCT protocol may
impose additional costs to hospitals and patients that may not be representative
of routine care. Additionally, these studies are often powered to demonstrate
significance in clinical outcomes rather than cost-effectiveness. Finally, these
piggyback studies may lack external validity as the patients selected for the
study may not represent the general population, and they are being treated
under restrictive circumstances. Thus, a more meaningful design includes costeffectiveness as the primary outcome, thereby depicting routine clinical practice
in costs and outcomes 13.
There are two methods of capturing costs included in a cost-analysis. One
method is gross-costing, where estimates are used to derive a final cost. This is
in contrast to micro-costing, which attempts to attach an exact cost to each
resource consumed by each patient during an intervention. Immediacy of cost
calculations is the major advantage of using a gross-costing method. Microcosting is much more labour-intense, but if done well, would provide a grosscosting estimate for future studies. Although costs used for both methods can
be acquired retrospectively, the analyst must consider the generalizability of the
data used and whether it satisfies the chosen perspective 13.
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2.2.1.7.1

Direct costs

Direct costs refer to the dollar amounts required to run an intervention or
treatment algorithm in a cost-analysis 83. These costs can be subdivided into
direct medical/health care costs and direct nonmedical/non-health care costs.
Direct medical/health care costs include expenditures such as inpatient
hospitalization, medications, radiographs, laboratory investigations, or implants
for a THA. Direct nonmedical/non-health care costs are other expenditures
required for completion of an intervention, such as patient transportation, care
on behalf of family members, gait aids, or home modifications. These direct
costs are contained in the numerator of a cost-effectiveness ratio 13, 83.
When considering the societal perspective for a cost-analysis, it is sometimes
difficult to account for direct costs such as time spent waiting for treatment or
unpaid caretaking on behalf of family members (also known as home
production). In general, most cost-analyses apply the average wage of a person
of similar gender and age to those opportunity costs. In this way, the external
validity of the costs contained in the numerator will be optimized 13.

2.2.1.7.2

Indirect/productivity costs

Indirect/productivity costs are other cost considerations for cost-analysis. The
morbidity caused by an intervention may result in lost time to work, or the
inability to partake in leisure activity. There is also lost productivity due to
mortality associated with particular interventions or disease states 83. The time
lost to work or leisure activity during recovery from an intervention such as
surgery would undoubtedly have financial implications for the patient, as well as
impacting their health-related quality of life. In cost-analysis, these productivity
costs are included in the denominator of a cost-effectiveness ratio and are
reflected in health outcomes such as QALYs. Productivity costs can be
monetized for the purposes of cost-benefit analysis when necessary 13.
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2.2.1.8

Methods of assessing effectiveness

As mentioned earlier, cost-utility analysis is a type of cost-analysis. It is based
on utility theory, which states that individuals place preference-weights on
particular states of health 83. Several questionnaires have been developed to
capture a utility index, with values ranging from 1 (perfect health) to 0 (death),
and any negative value representing states of health perceived to be worse
than death 8, 13, 85-87. As discussed in the section on the EQ-5D, this utility index
allows the analyst to calculate QALYs 13.
Health-related quality of life determines each utility index. Several dimensions
encompass health-related quality of life, such as physical function,
psychological function, sensory impairment, social function, and pain. Again,
questionnaires that allow derivation of a utility index are based on population
studies where individuals have been asked to place preference weights on
certain health states. The preference weights used in these questionnaires are
typically derived from two methods: standard gamble or time-tradeoff
(discussed earlier under EQ-5D) 13.
The standard gamble method literally asks respondents to gamble with various
states of health. First, they are asked whether they would want to live
indefinitely with an assigned state of health. If not, the individual can choose to
gamble on achieving a full state of health or death. The probabilities of
achieving the various health states are altered until the individual feels there is
no difference between accepting the assigned state of health or gambling 88.
Many behavioural scientists contest that the general population may have
difficulty gambling on states of health, thus limiting the utility of this approach 13.
Quality-adjusted life years are then calculated by multiplying the utility index by
the length of time spent in that health state. The benefits of using QALYs are
that they not only capture improvements in health-related quality of life while
two cohorts are alive, but they also determine health-related quality of life from
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prolonged life if there is a mortality benefit from undergoing a particular
intervention 13.

2.2.1.9

Time horizons

Cost-analysis involves time horizons. A time horizon refers to an interval of time
required to observe potential health-related and economic implications of an
intervention. In medicine, most investigators are interested in the lifelong effects
of a treatment or procedure. Therefore, most prospective studies are not
capable of capturing health and economic data with a time horizon equivalent to
the length of a human life 13.
In order to accommodate for this, many studies use models to extrapolate cost
and health effects of an intervention until a person’s death. Many cost-analyses
will report prospectively collected cost data using a short time horizon that
includes the follow-up outlined in the study, and model a second set of data to
include the longer time horizon 13.

2.2.2 Cost-analysis in total hip arthroplasty
Total hip arthroplasty has been subjected to cost-analysis, with the earliest
studies dating back to the 1990s 75, 77. Although THA is an effective treatment
modality for debilitating hip arthritis, it is an expensive procedure performed
more frequently each year 73, 89-92. For example, the Canadian Institute for
Health Information reported that the number of hip and knee replacements
performed in Canada increased from 82,700 in 2007 to 93,450 in 2011. In the
United States, some authors suggest that upwards of 500,000 THAs will be
performed annually by 2030 73. These figures will undoubtedly place a
tremendous burden on financial resources available for health-care
administration. Therefore, it is important to understand the burden of hip
osteoarthritis, and the cost associated with common procedures such as THA.
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2.2.2.1

Economic burden of hip arthritis

Several studies have tried to capture the direct and indirect costs for patients
living with arthritis. A Canadian study by Maetzel et al. determined that the
costs incurred by patients living with osteoarthritis amounts to $5700 annually
(1999 Canadian dollars). Sixty-nine percent of these costs are direct, such as
hospitalization, drugs, and assistive devices, and 31% are indirect costs 93. In
Canada, the overall financial burden of osteoarthritis was estimated to be
between 4.3 and 7.3 billion dollars (1994 Canadian dollars) 93. A study in the
United States by Leigh et al. quoted an annual cost of 89 billion dollars for allcomers with osteoarthritis (1994 US dollars) 94. As life is prolonged through
medical advancements, the number of individuals living with arthritis will rise
and continue to incur tremendous health-care costs 73.
There are few studies capturing the costs incurred by patients living with hip
arthritis. One study by Gupta et al. used questionnaires to acquire direct and
indirect costs over 2 years in 1200 Canadians living with arthritis of their hip or
knee. The WOMAC questionnaire was used to assign disease severity to each
participant. Their perspective was that of the patient, thus they excluded several
direct costs including hospital admissions, prescription drugs, and
physiotherapy. They determined an average cost of $12,200 annually (2002
Canadian dollars), where approximately $10,000 of this total encompassed
indirect costs (i.e. home-care programs, paid employment time lost, and costs
of caregivers). Predictors of increasing costs were advanced age, more severe
arthritis based on WOMAC performance, and lower socioeconomic status 95.
Unfortunately, these costs were not reported separately for hip and knee
arthritis. The cost information was also dependent on patient recall, thereby
limiting the accuracy of the aggregated cost 96.
Another study prospectively acquired direct medical costs of 70 Australians
living with hip or knee arthritis. A customized cost questionnaire was distributed
to study participants in 4 3-month intervals. The maximum annual direct medical
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costs incurred to patients in this study was $2,700 (1994 Australian dollars).
Predictors of increased expenditures included female sex, age over 65, poorer
performance on both the WOMAC and SF-36 questionnaires, and living with
arthritis for a prolonged period of time 97. Although this study captured many
“out-of-pocket” costs that patients may encounter living with arthritis, it did not
collect information on direct non-medical costs or indirect costs.
A more recent study by Rolfson et al. examined the costs of 2635 Swedish
individuals with hip arthritis on the surgical waiting list for THA. A cost
questionnaire was distributed to each patient, which outlined working status (i.e.
working, retired, sick leave, or disability support pension), living situation,
medications, community support, modifications made to living arrangements
(i.e. wheelchair accessibility), transportation costs, and care from other
individuals. The participants were asked to report information for the 12 months
prior to receiving the questionnaire. Estimates were used to approximate costs
of community home care and home modifications. Age and gender-specific
mean incomes were used to estimate productivity losses for those taking time
away from paid employment, as well as costs incurred to those providing
informal care. The investigators also examined time spent waiting for both
orthopedic consultation and the day of surgery 98.
The results of the study suggest an average annual cost of $7,666 for patients
living with hip arthritis (2009 US dollars). Sixty-seven percent of the study
population was retired at the time the questionnaire was distributed. Of those
individuals not working, approximately 60% were on some form of sick leave or
disability. Five percent of the cohort reported some form of home care, while
43% of respondents had some form of home modification because of hip
arthritis. Almost one-quarter of the study population required informal
assistance from another caregiver. The mean wait time for orthopedic
consultation was 176 days, while the mean time to surgery following
consultation was 144 days. The majority of the reported costs (61%) were due
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to productivity losses (indirect costs) 98. This study provides useful information
on many of the indirect costs incurred by patients living with hip arthritis in a
publically funded health care system similar to Canada. Although the
denominator of a cost-effectiveness ratio reflects productivity losses, this study
illustrates the financial burden of hip arthritis for both patients and society 13.

2.2.2.2

Cost of total hip arthroplasty

Few studies have provided accurate estimations of the cost of THA. A multicenter study performed in Canada and the United States determined the mean
direct costs of a THA to be $6,766 and $13,339, respectively (2001 US dollars).
Interestingly, this difference was evident despite a significant difference in the
mean length of stay between the two countries: 4.2 days for the United States
centers and 7.2 days for the Canadian centers. There was also a marked
difference in the cost of implants between the two nations, with medians costs
of $8,017 and $1,695 for the United States and Canada, respectively (2001 US
dollars). The cost of the implants, along with differences in overhead costs
(administration, house-keeping, etc.), explained the cost disparity between the
two countries 91. This study provides useful information from a payer’s
perspective on how different health care budgeting frameworks can impact
overall costs. However, it does not account for several other direct medical and
non-medical costs associated with THA in the post-operative period.
Another study examined costs associated with undergoing either a hip or knee
replacement in Canada. Hospital costs associated with the index procedure and
post-operative direct medical and non-medical costs were aggregated up to 6months following THA. The analysts determined a cost of $14,761 over the 6month period (2007 Canadian dollars). Costs were not disseminated for hip and
knee replacements separately. Also, it was unclear how they determined
relevant outpatient rehabilitative costs 99.
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2.2.2.3

Is total hip arthroplasty cost-effective?

It is clear from the discussion that THA is an expensive procedure to both the
patient and the purveyor of health care resources. In Canada, with the number
of THA procedures approaching 50,000 per year, millions of dollars will be
spent to treat debilitating hip arthritis 90. However, the pain mitigation and
restoration of function attained following this procedure is almost incomparable
1, 4

. Although cost-analyses are sparse in the realm of THA, those that have

been reported suggest it may be the most cost-effective procedure in all of
medicine 1, 77.
The study composed by Chang and colleagues is considered the benchmark in
cost-analysis and THA. Their goal was to determine the cost-effectiveness of
THA versus no treatment for osteoarthritis of the hip. The analysts used a
model to determine long-term costs and functional outcomes in these two
cohorts. A stochastic tree was used to model transition rates between health
states, such as undergoing a THA and then dying peri-operatively, and the risk
of other related health events, such as peri-prosthetic infection, aseptic
loosening, peri-prosthetic fracture, or death from unrelated causes. This analytic
technique was also used to model non-operative management, which includes
either further functional deterioration or death from unrelated causes.
Probabilities of peri-operative and natural mortality and revision rates were
acquired from published literature. A societal perspective was taken to allow for
comparison against other medical interventions 77.
In order to measure effectiveness, they used the American College of
Rheumatology (ACR) functional status classification. This classification ranges
from I to IV, where class I would be the ability to complete all usual activities,
and class IV is essentially being bed-ridden because of hip pain 100. Class III on
the ACR classification was the prerequisite for needing a THA in their model
(the ability of the patient to perform little to none of their usual activities). The
authors used expert consensus to determine which ACR class corresponded
79

with Harris Hip and Mayo Hip scores in the literature. This allowed the authors
to assign primary and revision THA procedures to a particular ACR class in
their model. A standard gamble assessment was used to assign each ACR
class a utility value to allow for the determination of QALYs 77.
Costs were tabulated for both THA and those patients treated conservatively
without surgery. Most of the costs used in the analysis were direct medical
costs, including hospital admissions, time spent in the operating room, costs of
the implants, physiotherapy, physician billings, and investigations. The cost
data was largely derived from a hospital accounting system and averages from
reported health care institutions such as nursing homes 77.
With regards to their final analysis, the authors examined cost-effectiveness in
men and women in 4 age categories: 60 years, 70 years, 80 years, and older
than 85 year. At the extremes, THA was projected to be a cost-saving
intervention in women aged 60 or younger. In men older than 85, the costeffectiveness ratio was $6100/QALY (1991 US dollars). Their model suggested
that THA was still cost-effective even when revision rates were increased and
peri-operative mortality increased 77. At that time, the only other comparable
surgical intervention included coronary artery bypass graft for left main coronary
artery disease, which had a reported cost-effectiveness ratio of $8100/QALY
(1991 US dollars) 101.
Cost-analyses are undoubtedly important tools in implementing innovative
medical technologies given finite resources. Since 1996, cost-analysis has been
used in the realm of THA to assess new bearing surfaces, fixation methods,
and prosthetic implants 78-80. More recent cost-analysis studies have examined
the cost-effectiveness of resurfacing hip arthroplasty versus conventional THA,
and types of THA fixation 102, 103.
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Surgical approach in THA is an area that warrants further investigation with
regards to associated costs. This literature review outlines the differences in
operating room time, length of stay in hospital, and time to functional recovery
between the approaches. Each of these variables may have a significant impact
on costs in THA, which is one of the rationales behind this thesis.
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2.3 Rationale for thesis
This literature review has outlined some of the comparative studies examining
surgical approach in total hip arthoplasty. There is still a paucity of robust
prospective studies comparing the three most common surgical approaches
used in THA. Many of the comparative studies failed to use validated outcome
measures to determine effectiveness. As well, the lack of inclusion of generic
clinical questionnaires such as the SF-12 prohibits any discussion on the
psychological effect of surgical approach in THA. The first study of this thesis
will include a prospective comparison between the three surgical approaches
using various validated outcome questionnaires.
This chapter also reviewed the role cost-analysis has played in the arthroplasty
literature. Surgical approach in THA has never been subjected to a costanalysis. The second study will examine the impact of surgical approach on
costs following THA. This will include a comparison of various metrics such as
operating room time, length of stay in hospital, and complication rates, metrics
which surgeons find valuable when choosing a surgical approach for THA.
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2.4 Thesis objectives
This thesis has two primary objectives:
1. To compare various clinical outcomes across three different
surgical approaches used for THA.
2. To determine the impact of surgical approach on costs following
THA.

2.5 Thesis hypotheses
The hypotheses based on these objectives are:
1. There will be no difference on any of the validated outcome
measures across surgical approaches at early follow-up.
2. Surgical approach will have no significant impact on the costs
associated with THA.
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Chapter 3
3

Surgical approach in total hip arthroplasty: The impact
on short-term patient outcomes

3.1 Introduction
Sir John Charnley revolutionized the treatment of hip arthritis forever in the
1960s. His low friction hip arthroplasty stood as the framework for the modern
total hip arthroplasty (THA) 1. Although several tribologic advances have been
made in implant design and bearing articulations, THA remains the most
effective treatment modality for hip arthritis and is often regarded as one of the
most important surgical advances in all of history 2.
Basic science and clinical research remain integral components of improving
the effectiveness of THA. Clinical trials allow clinicians to determine the impact
of an intervention on a patient. These trials can also determine the indications
and contra-indications for each intervention, factors that influence success and
failure, and complications associated with a given procedure. Invaluable
information is acquired from these studies when informing patients of the risks
and benefits of any medical endeavor.
There are several methods of assessing the effectiveness of any intervention.
In the orthopedic literature, many clinical studies rely on validated, diseasespecific, and generic clinical questionnaires in order to document a patient’s
response to an intervention. Other outcome measures include metrics such as
operating room time, functional outcomes such as gait analyses, and
complication rates.
The impact of surgical approach on clinical outcomes in THA has been under
scrutiny over the past decade. Prospective and retrospective studies have
compared different surgical approaches in THA using a myriad of outcome
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measures. Very few studies have used validated clinical outcomes in their
comparisons, and to our knowledge none of the studies have standardized the
implants used at the time of the index procedure.
The primary objective of this study was to prospectively compare clinical
outcomes across three different surgical approaches to the hip for THA,
specifically the results on the Western Ontario and McMaster University
Osteoarthritis Index (WOMAC). Using validated outcome measures, we look to
elicit whether there is an early clinical benefit of performing a THA through an
anterior approach. We will also compare complication rates between the
approaches. We hypothesize that there will be no difference in clinical
outcomes between the three different surgical approaches at short-term followup.
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3.2 Materials and Methods
3.2.1 Study design, patient enrolment and selection
Institutional review board ethics approval was attained at Western University.
The study design was a prospective cohort observation study from a single
institution. Patients were first assigned to the clinic of one of three fellowshiptrained arthroplasty surgeons at University Hospital at Western University. The
surgeons were randomly assigned a day of the week to receive referrals from
our central accepting database. Although not truly a randomized process, this is
representative of usual clinical practice, thus strengthening the external validity
of the study. Each surgeon performed only one of three surgical approaches to
the hip: anterior (BL), posterior (JH), and lateral (EV). Informed consent for THA
was attained for those patients whose hip arthropathy was deemed most
appropriately treated with surgical intervention.
One hundred and seventy eight consecutive patients were then approached for
study enrolment in the preadmission clinic prior to their procedure from
September 2013 to July 2014. Patients were included if they consented for THA
performed through either an anterior, posterior, or lateral approach, were older
than 19 years of age, and did not meet any of the exclusion criteria (Table 3.1).
A letter of information was provided for each patient screened, followed by
voluntary consent for study participation.
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Exclusion Criteria
2

Body Mass Index (BMI) > 40 kg/m
Legg-Calve-Perthes disease, slipped-capital femoral epiphysis, or developmental dysplasia of
the hip (Crowe I or higher)
Post-traumatic or inflammatory arthropathy
Any previous hip surgery
Simultaneous bilateral THAs
Decision to change implants intra-operatively other than those approved for study
Cemented THA
Diagnoses that may preclude accurate completion of clinical questionnaires (i.e. Alcoholism,
dementia, psychoses)
Non-English speaking
Inability to perform Timed Up-and-Go test (TUG)
Cases performed by trainees (residents or clinical fellows)

Table 3.1 – Study exclusion criteria
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3.2.2 Patient demographics
At the time of enrolment, patient age, sex, and BMI were collected. The primary
diagnosis causing arthropathy of the hip joint (i.e. osteoarthritis, avascular
necrosis) was determined based on patient history and radiographic images.
Surgical approach and operative side were also recorded.

3.2.3 Determining clinical outcomes
Pre-operatively, each patient completed 4 different clinical questionnaires:
Harris hip score (HHS), WOMAC, Short-Form 12 (SF-12), and EQ-5D 3-6. These
questionnaires were administered at 6-weeks and 3-months following the index
procedure for post-operative comparison. The WOMAC, SF-12, and EQ-5D are
completed entirely by the patients and do not require any assistance from
health care personnel. Unblinded physicians or health care personnel other
than the treating surgeon completed the HHS. Any incomplete questionnaires
were not included in final statistical analyses. An anterior-posterior pelvis and
lateral hip radiograph were taken at the 6-week follow-up appointment to
assess implant positioning, and document any peri-prosthetic concerns (i.e.
fracture).
Each patient also completed a Timed up-and-go (TUG) test pre-operatively and
at the 6-week and 3-month post-operative intervals. The test begins with the
patient sitting in a chair with armrests. On the word “Go”, the patient walks to a
3-metre mark, turns, returns to the chair, and sits down 7. The time from the
word “Go” to the instant the patient’s buttock contacts the chair is recorded to
the nearest tenth of a second. The patient performs the test in their normal
footwear and is allowed to use an assisted device (i.e. cane). A time greater
than 10 seconds pre-operatively correlates with requiring a gait aid at 6-months
following THA 8. A time of 10 seconds also correlates with increased risk of falls
and inability to perform activities of daily living independently in patients with hip
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osteoarthritis 9. A minimally important difference of 1.4 seconds has been
reported in a population of patients living with hip arthritis 10.
Several other parameters will be compared between the surgical approaches.
Post-operative infections, peri-prosthetic fractures and dislocations, wound
complications, nerve palsies, and medical complications (i.e. myocardial
infarction or pulmonary embolism) are examples of complications used to
differentiate the three approaches. These were collected prospectively during
each hospital stay by means of a standardized In-hospital Stay Data Collection
Sheet (Appendix C).

3.2.4 Operative procedures
A single surgeon was designated to perform every case using one of the three
surgical approaches. There were no cases performed by trainees (i.e. residents
or fellows). Each patient received standardized implants: a hydroxyapatitecoated, cementless femoral stem (Corail TM stem, DePuy Orthopaedics Inc.,
Warsaw, IN), a cementless acetabular cup (Pinnacle Sector II TM acetabular
cup, DePuy Orthopaedics Inc., Warsaw, IN), a highly cross-linked polyethylene
liner (AltrX TM polyethylene liner, DePuy Orthopaedics Inc., Warsaw, IN), and a
cobalt chrome femoral head (Articul/eze TM cobalt chrome, DePuy Orthopaedics
Inc., Warsaw, IN). Cancellous screws (DePuy Orthopaedics Inc., Warsaw, IN)
were inserted in order to augment acetabular fixation at the surgeon’s
discretion.
The anterior approach was performed using a modified Hueter approach 11. The
patient was positioned supine on a specialized operating table (Hana TM fracture
table, Mizuho OSI, Union City, CA). An incision was made 2 centimeters lateral
to the anterior superior iliac spine, extending distally towards the superolateral
patella for 8 to 10 centimeters. The superficial inter-nervous interval between
tensor fascia latae and sartorius was incised, protecting the lateral femoral
cutaneous nerve. The deep inter-nervous interval between gluteus medius and
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rectus femoris was then incised, exposing the anterior joint capsule. A
longitudinal capsulotomy was performed along the long axis of the femoral
neck, extending from the acetabulum to the intertrochanteric line. Using a
reciprocating saw, a femoral neck osteotomy was performed with appropriate
soft tissue retractors in place. A corkscrew was used to remove the femoral
head, and a napkin ring osteotomy of the femoral neck was used as needed to
facilitate femoral head removal. The operative leg was then carefully externally
rotated to aid in visualizing the acetabulum. Intra-operative fluoroscopy was
used to verify inclination and anteversion during acetabular reaming. For
femoral preparation, the operative leg is carefully extended, adducted, and
externally rotated. A femoral bone hook on a motorized bracket was used to aid
in visualizing the proximal metaphysis during preparation. Intra-operative
fluoroscopy was used to verify stem size, femoral offset, and restoration of leg
lengths. The wound was irrigated and closed in layers.
The lateral approach was performed using the technique described by Hardinge
12

. The patient was positioned in the lateral decubitus position. An incision was

fashioned centered over the tip of the greater trochanter, extending 3
centimeters proximally and 5 centimeters distally. The fascia latae was incised
in line with the skin incision. A one-half anterior, one-half posterior split was
made in the gluteus medius muscle. A tenotomy of the tendinous insertion of
gluteus medius was performed, leaving a cuff of tissue for repair at the end of
the case. The gluteus minimus and joint capsule were then dissected off the
femoral neck in a single layer. The hip was then dislocated with the operative
limb placed in a sterile bag. A femoral neck osteotomy was performed 1
centimeter proximal to the lesser trochanter. This then provided adequate
visualization of both the acetabulum and femur for preparation, which were
performed in the usual fashion. The wound is thoroughly irrigated and closed in
layers. Careful attention was taken when closing the gluteus medius tenotomy
to prevent post-operative abductor insufficiency.
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The posterior approach utilized the technique popularized by Moore 13. The
patient was positioned in the lateral decubitus position. A skin incision extended
along the posterior aspect of the greater trochanter, curving towards the
posterior superior iliac spine. The fascia overlying the gluteus maximus was
incised in line with the skin incision. The gluteus maximus was bluntly dissected
down to the short external rotators. The surgeon protected the sciatic nerve with
soft tissue retraction without formal exploration. The conjoint tendon (superior
and inferior gemelli and obturator internus) and piriformis were dissected off the
greater trochanter and tagged with a suture for later repair. A capsulotomy was
performed, followed by femoral neck osteotomy. This provided adequate
exposure to perform both the acetabular and femoral reconstructions. The joint
capsule and short external rotators are repaired through trans-osseous tunnels
in the greater trochanter. The remainder of the wound is closed in layers.

3.2.5 Post-operative care
Post-operatively, all patients were admitted to an orthopedic ward. Each patient
received 24 hours of post-operative antibiotics, as well as prophylaxis against
deep vein thrombosis. Analgesia was managed by our institution’s acute pain
service. All patients were permitted to weight-bear as tolerated with the use of a
gait aid as needed. All patients received standardized, unblinded physiotherapy
in accordance with our institution’s hip arthroplasty discharge pathway.

3.2.6 Sample size calculation
There are few studies comparing validated clinical outcome measures using
different surgical approaches in THA. Restrepo et al. found an effect size of
0.67 with the WOMAC questionnaire at 6-weeks as their primary endpoint
between the anterior and lateral approach 14. To take a conservative approach
we used an effect size of 0.60, alpha set at 0.05, and a power of 0.80. This
results in 36 participants in all groups. To account for attrition, we inflated the
sample size by 10%. Therefore, we will enroll 40 patients per group.
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3.2.7 Statistical analysis
The association between the anterior, posterior, and lateral approaches and
demographic categorical data such as sex and operative side were evaluated
by means of a nonparametric Pearson Chi-square. A one-way analysis of
variance (ANOVA) was performed for continuous demographic variables such
as age and BMI.
The mean ranks of the domains of the EQ-5D pre-operatively and at each
follow-up time point was evaluated the Kruskal-Wallis test. Those comparisons
demonstrating statistical significance were then followed by post hoc, pair-wise
testing using the Mann-Whitney test.
A one-way ANOVA was used to compare pre-operative, 6-week, and 3-month
outcome measures (HHS, WOMAC, SF-12, EQ-5D VAS and utility index, and
TUG) across the 3 surgical approaches. Post-hoc analysis was performed using
the Scheffé test to determine significant differences between the groups when
necessary. Statistical significance was set at p<0.05. The SPSS® v.22 (SPSS
Inc, Chicago, IL, USA) was used for all analyses.
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3.3 Results
3.3.1 Patient demographics
Figure 3.1 represents a flow diagram outlining recruitment, patient exclusions,
and follow-up. Sixty patients were excluded after random assignment for
reasons listed in the flow diagram. All groups had complete pre-operative
outcome measure data. Table 3.2 outlines the number of patients with missed
follow-up at the 6-week and 3-month time-points, and reasons for the missed
appointments.

Patient demographics of the 118 patients enrolled in the study are outlined in
Table 3.3. There were no statistically significant differences between the groups
with regards to age and BMI following a one-way ANOVA. Sex, operative side,
and primary diagnosis distributions were also not statistically different following
Pearson Chi-square analysis.
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178 Patients Assigned to 3 Approaches

60 Patients Excluded:
- BMI > 40 kg/m2 = 7
- Acetabular dysplasia / developmental dysplasia = 7
- Unable to walk unassisted for TUG = 7
- Inflammatory arthropathy = 6
- Post-traumatic arthritis = 5
- Previous hip surgery = 5
- Cognitively impaired = 4
- Non-English speaking = 4
- Declined participation = 4
- Different implants used = 3
- Simultaneous THA = 2
- Other: 6

Anterior Approach = 40

Lateral Approach = 40

Posterior Approach = 38

Complete Data
(Outcomes, TUG):
- Pre-op = 40
- 6-weeks = 37
- 3-months = 36

Complete Follow-up Data
(Outcomes, TUG):
- Pre-op = 40
- 6-weeks = 36
- 3-months = 36

Complete Follow-up Data
(Outcomes, TUG):
- Pre-op = 38
- 6-weeks = 34
- 3-months = 26

Figure 3.1 – Flow diagram for study
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Number of patients
with missed 6-week
data

Number of patients
with missed 3-month
data

Anterior Approach

Posterior Approach

Lateral Approach

n=3

n=4

n=4

Reason:

Reason:

Reason:

- 2 due to travel

- 2 due to travel

- 1 due to travel

- 1 patient could not
be contacted

- 2 patients could not
be contact

- 3 patients could
not be contacted

n=4

n=12

n=4
Reason:

Reason:

Reason:

- 3 patients still
require 3-month
follow-up

- 2 due to travel

- 2 due to travel

- 2 patients refused 3month follow-up

- 2 patients could
not be contacted

- 1 patient could not
be contacted

- 2 patients could not
be contacted
- 6 patients still require
3-month follow-up

Table 3.2 – Missed follow-up appointments
An outline of the reasons for missing data at the 6-week and 3-month follow-up
appointments.
Demographic

Anterior Approach

Posterior Approach

Lateral Approach

Age (years)

Mean = 66.9
Std. Dev. = 9.5
Range = 42 - 86
Female = 25
Male = 15
Mean = 27.9
Std. Dev. = 4.3
Range = 20.8 – 36.4
Left = 22
Right = 18
Osteoarthritis = 37
Avascular Necrosis = 3

Mean = 66.7
Std. Dev. = 9.2
Range = 44 - 84
Female = 24
Male = 14
Mean = 28.2
Std. Dev. = 5.3
Range = 16.2 – 39.9
Left = 18
Right = 20
Osteoarthritis = 33
Avascular Necrosis = 5

Mean = 65.5
Std. Dev. = 10.4
Range = 42 – 92
Female = 26
Male = 14
Mean = 29.1
Std. Dev. = 5.6
Range = 19.9 – 39.9
Left = 18
Right = 22
Osteoarthritis = 38
Avascular Necrosis = 2

Sex
Body Mass
2
Index (kg/m )
Operative
Side
Primary
Diagnosis

Table 3.3 – Patient demographics
Sample demographics with means, standard deviations, and ranges for
continuous variables.
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pvalue
0.792

0.971
0.541

0.647
0.418

3.3.2 Clinical outcome measures
3.3.2.1

Western Ontario and McMaster University
Osteoarthritis Index

The results of the pre-operative, 6-week, and 3-month WOMAC can be found in
Figure 3.3. The descriptive statistics from the comparison can be found in Table
3.5.
There were no statistically significant differences between the 3 groups for the
pre-operative WOMAC pain, stiffness, function, and total score. At 6-weeks,
there was a statistically significant difference between the groups for the
function composite score, but not the pain, stiffness, and total score. Pair-wise
post-hoc testing demonstrated that the anterior group scored higher than the
lateral group on the 6-week function score (p=0.036). At 3-months, there were
no statistically significant differences between groups for all of the WOMAC
composite scores.
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WOMAC Results
100
90
80

Mean Score

70
60
50
Anterior
40
Posterior
30

Lateral

20
10

Pre-op

6-weeks

Total

Function

Stiffness

Pain

Total

Function

Stiffness

Pain

Total

Function

Stiffness

Pain

0

3-months

Figure 3.2 – Results of WOMAC
Mean scores for each component score for the WOMAC at all time points. Error
bars represent 95% confidence intervals. Pair
Pair-wise
wise comparisons reaching
statistical significance for a given composite score are denoted by symbols.
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Anterior
Approach (mean
+/- SD)
45.8 +/- 19.1

Posterior
Approach (mean
+/- SD)
43.4 +/- 20.0

Lateral
Approach
(mean +/- SD)
46.4 +/- 21.0

p-value

39.2 +/- 22.3

35.9 +/- 17.7

41.8 +/- 24.1

0.536

42.8 +/- 18.1

41.5 +/- 17.0

45.3 +/- 18.8

0.684

43.3 +/- 17.2

41.1 +/- 17.1

45.0 +/- 18.9

0.661

6-week WOMAC
Pain
6-week WOMAC
Stiffness
6-week WOMAC
Function
6-week WOMAC
Total

83.5 +/- 15.6

84.6 +/- 17.2

79.5 +/- 16.0

0.444

76.7 +/- 16.7

72.6 +/- 18.7

68.2 +/- 15.7

0.139

86.9 +/- 12.9

81.1 +/- 16.8

77.2 +/- 14.1

0.036

83.3 +/- 13.2

80.3 +/- 15.8

76.3 +/- 13.2

0.141

3-month WOMAC
Pain
3-month WOMAC
Stiffness
3-month WOMAC
Function
3-month WOMAC
Total

90.2 +/- 11.2

90.9 +/- 11.9

88.0 +/- 13.0

0.646

79.3 +/- 21.7

76.7 +/- 19.4

75.4 +/- 16.4

0.715

89.2 +/- 10.0

89.4 +/- 11.4

87.1 +/- 12.4

0.680

87.4 +/- 11.1

87.3 +/- 11.7

85.0 +/- 11.7

0.638

Pre-operative
WOMAC Pain
Pre-operative
WOMAC Stiffness
Pre-operative
WOMAC Function
Pre-operative
WOMAC Total

0.818

Table 3.4 – Descriptive statistics for the WOMAC
Descriptive statistics including means and standard deviations are outlined in
the table, as well as the p-values for the one-way, between-group ANOVA for
the WOMAC.
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3.3.2.2

Harris hip score

The results of the pre-operative, 6-week, and 3-month HHS can be found in
Figure 3.2. The descriptive statistics for the ANOVA can be found in Table 3.4.
There were no statistically significant differences between the 3 groups for the
pre-operative Harris hip pain, function, and total score. At 6-weeks, there was a
statistically significant difference between the groups for the function score, but
not the pain and total scores. Post-hoc pair-wise testing demonstrated that the
posterior approach cohort scored significantly higher on the 6-week function
score (p=0.037) than the lateral approach group. The 6-week functional score
for the anterior approach group nearly reached statistical significance when
compared to the lateral approach group (p=0.057). Finally, at 3-months, there
were no statistically significant differences between the 3 groups for all of the
HHS composite scores.
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Harris Hip Score Results
100
90
80

Mean Score

70
60
50
Anterior
40

Posterior
Lateral

30
20
10

Pre-op

6-weeks

Total Score

Function

Pain

Total Score

Function

Pain

Total Score

Function

Pain

0

3-months

Figure 3.3 – Results of Harris hip score
Mean scores for each component score for the Harris hip score at all time
points. Error bars represent 95% confidence intervals. Pair
Pair-wise
wise comparisons
reaching statistical significance for a given composi
composite
te score are denoted by
symbols.
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Pre-operative
HHS Pain
Pre-operative
HHS Function
Pre-operative
HHS Total
6-week HHS Pain
6-week HHS
Function
6-week HHS Total
3-month HHS
Pain
3-month HHS
Function
3-month HHS
Total

Anterior
Approach (mean
+/- SD)
20.0 +/- 7.3

Posterior
Approach (mean
+/- SD)
18.4 +/- 6.8

Lateral
Approach
(mean +/- SD)
18.6 +/- 8.8

p-value

28.2 +/- 7.1

27.3 +/- 8.7

28.9 +/- 9.9

0.760

54.4 +/- 12.3

51.5 +/- 14.8

52.8 +/- 17.8

0.738

41.3 +/- 4.5
39.6 +/- 7.6

41.6 +/- 4.7
40.7 +/- 6.9

42.6 +/- 2.9
35.0 +/- 6.8

0.430
0.017

89.6 +/- 11.3

90.8 +/- 9.5

86.0 +/- 8.4

0.228

42.7 +/- 4.5

41.3 +/- 7.2

43.6 +/- 1.2

0.208

42.9 +/- 5.7

42.1 +/- 6.6

41.1 +/- 6.4

0.494

94.6 +/- 8.8

91.9 +/- 10.4

93.6 +/- 6.5

0.535

0.642

Table 3.5 – Descriptive statistics for Harris hip score
Descriptive statistics including means and standard deviations are outlined in
the table, as well as the p-values for the one-way, between-group ANOVA for
the HHS.
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3.3.2.3

Short-form 12

The results of the pre-operative, 6-week, and 3-month SF-12 Mental and
Physical Component Summary scores (MCS and PCS, respectively) can be
found in Figure 3.4. The descriptive statistics for this comparison can be found
in Table 3.6. There were no statistically significant differences between the
groups for any time point for the MCS and PCS scores of the SF-12.
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SF-12 Results
70
60

Mean Score

50
40
Anterior
30

Posterior
Lateral

20
10
0
MCS

PCS
Pre-op

MCS

PCS

6-weeks

MCS

PCS

3-months

Figure 3.4 – Results of SF-12
Mean scores for each component score for the SF
SF-12
12 at all time points. Error
bars represent 95% confidence intervals
intervals.
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Pre-operative SF12 – MCS
Pre-operative SF12 – PCS
6-week SF-12 –
MCS
6-week SF-12 –
PCS
3-month SF-12 –
MCS
3-month SF-12 –
PCS

Anterior
Approach (mean
+/- SD)
53.4 +/- 10.2

Posterior
Approach (mean
+/- SD)
49.7 +/- 13.2

Lateral
Approach
(mean +/- SD)
51.5 +/- 11.5

p-value

30.7 +/- 7.4

31.0 +/- 9.1

31.2 +/- 7.8

0.975

57.2 +/- 7.0

55.4 +/- 9.1

53.6 +/- 10.0

0.280

40.8 +/- 10.4

35.9 +/- 9.8

35.8 +/- 8.8

0.087

56.5 +/- 6.6

54.5 +/- 11.2

58.7 +/- 5.7

0.150

45.4 +/- 9.9

47.1 +/- 10.2

44.2 +/- 8.3

0.554

0.468

Table 3.6 – Descriptive statistics for the SF-12
Descriptive statistics including means and standard deviations are outlined in
the table, as well as the p-values for the one-way, between-group ANOVA for
the SF-12.
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3.3.2.4

EQ-5D

The results outlining the pre-operative, 6-week, and 3-month dimension
distributions for the EQ-5D questionnaire can be found in Tables 3.7, 3.8, and
3.9, respectively. Pair-wise Mann-Whitney tests revealed that the pre-operative
distribution of self-care was significantly different for the anterior versus
posterior approach (p=0.008). At 6-weeks, the distribution of usual activities
was significantly different for the anterior versus posterior (p=0.044) and
anterior versus lateral (p=0.007) comparisons. At 3-months, the distribution of
anxiety and depression was significantly different for the anterior versus lateral
(p=0.018) and posterior versus lateral (p=0.004) comparisons.
The results of the pre-operative, 6-week, and 3-month EQ-VAS and EQ-5D
utility index can be found in Figures 3.5 and 3.6. The descriptive statistics for
these comparisons can be found in Tables 3.10 and 3.11. There were no
statistically significant differences between the groups for any time point for EQVAS and utility index.
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EQ-5D Dimension

Anterior
Approach

Posterior
Approach

Lateral
Approach

KruskalWallis test

Level 1
Level 2
Level 3

7.5%
90.0%
2.5%

11.1%
86.1%
2.8%

7.7%
92.3%
0.0%

0.887

Level 1
Level 2
Level 3
Usual Activities
Level 1
Level 2
Level 3
Pain / Discomfort
Level 1
Level 2
Level 3
Anxiety /
Depression
Level 1
Level 2
Level 3

45.0%
55.0%
0.0%

75.0%
25.0%
0.0%

56.4%
43.6%
0.0%

0.030

7.5%
77.5%
15.0%

2.8%
77.8%
19.4%

10.3%
74.4%
15.4%

0.566

2.5%
55.0%
42.5%

2.8%
50.0%
47.2%

1.7%
56.5%
41.7%

0.713

57.5%
40.0%
2.5%

47.2%
47.2%
5.6%

64.1%
28.2%
7.7%

0.414

Mobility

Self-Care

Table 3.7 – Pre-operative EQ-5D dimension distribution
Percent distributions across the 3 surgical approaches for pre-operative Level 1
(no problems), Level 2 (some problems), and Level 3 (severe problems)
responses for the EQ-5D dimensions. Refer to the text for pair-wise
comparisons when significance on the Kruskal-Wallis test is less than 0.05.
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EQ5D Dimension

Anterior
Approach

Posterior
Approach

Lateral
Approach

KruskalWallis test

Level 1
Level 2
Level 3

64.9%
35.1%
0.0%

50.0%
50.0%
0.0%

55.6%
44.4%
0.0%

0.461

Level 1
Level 2
Level 3
Usual Activities
Level 1
Level 2
Level 3
Pain / Discomfort
Level 1
Level 2
Level 3
Anxiety /
Depression
Level 1
Level 2
Level 3

89.2%
10.8%
0.0%

80.0%
20.0%
0.0%

77.8%
22.2%
0.0%

0.403

51.4%
43.2%
5.4%

26.7%
63.3%
10.0%

16.7%
80.6%
2.8%

0.017

2.5%
55.0%
42.5%

2.8%
50.0%
47.2%

1.7%
56.5%
41.7%

0.512

57.5%
40.0%
2.5%

47.2%
47.2%
5.6%

64.1%
28.2%
7.7%

0.383

Mobility

Self-Care

Table 3.8 – 6-week EQ-5D dimension distribution
Percent distributions across the 3 surgical approaches for the 6-week Level 1
(no problems), Level 2 (some problems), and Level 3 (severe problems)
responses for the EQ-5D dimensions. Refer to the text for pair-wise
comparisons when significance on the Kruskal-Wallis test is less than 0.05.
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EQ5D Dimension

Anterior
Approach

Posterior
Approach

Lateral
Approach

KruskalWallis test

Level 1
Level 2
Level 3

78.1%
21.9%
0.0%

83.7%
16.3%
0.0%

70.0%
30.0%
0.0%

0.577

Level 1
Level 2
Level 3
Usual Activities
Level 1
Level 2
Level 3
Pain / Discomfort
Level 1
Level 2
Level 3
Anxiety /
Depression
Level 1
Level 2
Level 3

96.4%
3.6%
0.0%

94.7%
5.3%
0.0%

89.7%
10.3%
0.0%

0.571

67.9%
32.1%
0.0%

68.4%
26.3%
5.3%

65.5%
34.5%
0.0%

0.983

64.3%
35.7%
0.0%

68.4%
26.3%
5.3%

48.3%
51.7%
0.0%

82.1%
17.9%
0.0%

73.7%
26.3%
0.0%

100.0%
0.0%
0.0%

Mobility

Self-Care

0.365

0.021

Table 3.9 – 3-month EQ-5D dimension distribution
Percent distributions across the 3 surgical approaches for 3- month Level 1 (no
problems), Level 2 (some problems), and Level 3 (severe problems) responses
for the EQ-5D dimensions. Refer to the text for pair-wise comparisons when
significance on the Kruskal-Wallis test is less than 0.05.
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EQ-VAS Results
100
90
80
Mean EQ-VAS

70
60
Anterior
50

Posterior

40

Lateral

30
20
10
0
Pre-op
op

6-weeks

3-months

Figure 3.5 – Results of EQ-5D VAS
Mean scores for visual analogue scale of the EQ
EQ-5D
5D at all time points. Error
bars represent
resent 95% confidence intervals.
Anterior
Approach (mean
+/- SD)
66.5 +/- 20.4

Posterior
Approach (mean
+/- SD)
66.4 +/- 20.6

Lateral
Approach
(mean +/- SD)
68.3 +/- 17.9

p-value

6-week EQ-VAS

82.3 +/- 11.7

80.5 +/- 12.3

78.3 +/- 10.9

0.344

3-month EQ-VAS

84.8 +/- 12.0

87.1 +/- 10.6

83.6 +/- 11.4

0.576

Pre-operative EQVAS

0.889

Table 3.10 – Descriptive statistics for the EQ-VAS
EQ
Descriptive statistics including means and standard deviations are outlined in
the table, as well as the p
p-values for the one-way, between-group
group ANOVA for
the EQ-VAS.
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EQ
EQ-5D Utility Index Results
1
0.9

Mean Utility Index

0.8
0.7
0.6

Anterior

0.5

Posterior

0.4

Lateral

0.3
0.2
0.1
0
Pre-op

6-weeks

3-months

Figure 3.6 – Results of EQ-5D
5D utility index
Mean scores for the EQ
EQ-5D
5D utility index at all time points. Error bars represent
rep
95% confidence intervals.
Anterior
Approach (mean
+/- SD)
0.546 +/
+/- 0.190

Posterior Approach
(mean +/- SD)

6-week EQ5D utility
index
3-month EQ5D utility
index

Pre-operative
EQ-5D utility
index

pvalue

0.538 +/- 0.200

Lateral
Approach
(mean +/-- SD)
0.572 +/- 0.192

0.822 +/
+/- 0.136

0.763 +/- 0.142

0.756 +/- 0.086

0.051

0.868 +/
+/- 0.124

0.861 +/- 0.174

0.845 +/- 0.111

0.811

0.737

Table 3.11 – Descriptive statistics for the EQ
EQ-5D
5D utility index
Descriptive statistics including means and standard deviations are outlined in
the table, as well as the p
p-values for the one-way, between-group
group ANOVA for
the EQ-5D
5D utility index.
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3.3.2.5

Timed up-and-go test

The results of the pre-operative, 6-week, and 3-month TUG tests can be found
in Figure 3.7. The descriptive statistics for this comparison can be found in
Table 3.12. There were no statistically significant differences following a oneway ANOVA between the groups for any time point for the TUG test. All group
means fell under the 10-second benchmark predictive of performing activities of
daily living independently after 3-months post-operatively 9.
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Timed Up-and-go Results
20
18
16

Mean time (s)

14
12
Anterior
10

Posterior

8

Lateral

6
4
2
0
Pre
Pre-op
TUG

6-week TUG

3-month TUG

Figure 3.7 – Results of the TUG test
Mean times for the TUG test at all time points. Error bars represent
represen 95%
confidence intervals.
Anterior
Approach (mean
+/- SD)
15.6 +/
+/- 5.7

Posterior Approach
(mean +/- SD)

6-week TUG
test
3-month TUG
test

Pre-operative
TUG test

pvalue

16.8 +/- 10.6

Lateral
Approach
(mean +/-- SD)
16.7 +/- 9.3

11.7 +/
+/- 3.5

12.2 +/- 5.0

13.0 +/- 6.3

0.559

9.5 +/
+/- 2.4

9.0 +/- 2.4

9.5 +/- 3.0

0.802

0.783

Table 3.12 – Descriptive statistics for the TUG test
Descriptive statistics including means and standard deviations are outlined in
the table, as well as the p
p-values for the one-way, between-group
group ANOVA for
the TUG test.
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3.3.3 Complications
Table 3.13 provides a summary of the complications documented across all
three cohorts. There was a statistically significant difference in the number of
nerve palsies observed in THAs performed through an anterior versus lateral or
posterior approach (p=0.001). All 7 cases were injury to the lateral femoral
cutaneous nerve resulting in symptomatic paresthesia. All cases resolved with
expectant management at 3-month follow-up.
A single case of peri-prosthetic infection occurred in the anterior approach
group. The patient was a 72 year-old male with a BMI of 35.56 kg/m2 and a
primary diagnosis of avascular necrosis. He had a persistently draining wound
post-operatively that did not abate with community dressing changes. His initial
investigations included a leukocyte count of 4.8 x 10 9 / L, erythrocyte
sedimentation rate (ESR) of 28 mm/h, and a C-reactive protein (CRP) of 2.3
mg/L. The infection was diagnosed 18 days post-operatively. The patient was
admitted to hospital and treated with removal of the femoral stem, femoral
head, and polyethylene liner, irrigation and debridement, followed by
implantation of a new Corail TM femoral stem, cobalt chrome femoral head, and
highly cross-linked polyethylene liner. Intra-operative cultures grew
Staphylococcus epidermidis. He received a 6-week course of intravenous
cefazolin through a peripherally inserted central catheter. His latest ESR and
CRP were 8 mm/h and 0.9 mg/L, respectively, 3-months following the irrigation
and debridement.
The peri-prosthetic fracture occurred in a lady following a fall from standing
height onto the operative hip 11-weeks post-operatively. Plain radiographs
diagnosed a minimally displaced Vancouver AL peri-prosthetic fracture based on
the Vancouver classification 15. The fracture was treated non-operatively with
weight-bearing restrictions and went on to heal without further complication.
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The wound complication in the anterior approach group was a stitch abscess
diagnosed 4-weeks post-operatively. It was successfully treated with an incision
and drainage, community dressing changes, and 2 weeks of oral cephalexin.
The patient in the lateral approach group had a small dehiscence of the
proximal aspect of their incision that required community dressing changes to
allow for healing through secondary intent. This patient received 10 days of oral
cephalexin and required no further intervention.
The complications occurring in the “Other” category were intra-operative injuries
in the anterior approach group. One patient sustained an ipsilateral knee sprain
during limb manipulation using the Hana TM fracture table. A post-operative
radiograph ruled out fracture around the knee, and magnetic resonance
imaging (MRI) did not identify any intra-articular or soft tissue injury. The patient
was successfully treated with rehabilitation. The second case was an intraoperative ankle sprain sustained during limb manipulation using the Hana TM
fracture table. Plain radiographs did not identify any fracture, and this patient
also recovered well with rehabilitation. There were no medical complications
throughout all three cohorts.

Nerve Palsy
Dislocations
Peri-prosthetic
Infections
Peri-prosthetic
Fracture
Wound Complications
Other

Anterior
Approach
(n=40)
7 (17.5%)
0
1 (2.5%)

Posterior
Approach
(n=38)
0
0
0

Lateral
Approach
(n=40)
0
0
0

Pearson
Chisquare
0.001
1.000
0.388

0

1 (2.7%)

0

0.332

1 (2.5%)
2 (5.0%)

0
0

1 (2.5%)
0

0.628
0.148

Table 3.13 – Summary of group complications
A summary of complications diagnosed across all three surgical approach
cohorts during the course of the study. Significant differences between group
complication rates were identified with a Pearson Chi-square.
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3.4 Discussion
The purpose of this study was to determine whether surgical approach in THA
has a significant impact on short-term clinical outcomes in a randomly assigned
cohort. There were significant differences across the groups, primarily in
functional composite scores, when comparing both disease-specific and generic
clinical outcome measures. There were also significant differences in the
complication rates post-operatively across the 3 surgical approaches.
The anterior approach demonstrated superior functional scores on both a
disease-specific (WOMAC) and generic (EQ-5D, usual activities dimension)
outcome measure at 6-weeks versus the lateral approach. Both the WOMAC
and EQ-5D, unlike the HHS, are patient-reported outcome measures. This
reduces the chance of expectation bias, and thus committing a type I error,
associated with physician-reported outcome measures. Other studies in the
literature have supported this finding when comparing 6-week functional
composite scores or activities across the 3 different surgical approaches 14, 16.
Although the study was powered specifically on a WOMAC total score
difference a priori, the WOMAC has demonstrated good content validity and
internal consistency across the subscales (i.e. pain, stiffness, function), thus the
differences are still clinically relevant 4.
There are several reasons as to why the anterior approach may provide earlier
functional benefit following a THA. The anterior approach has been deemed a
“muscle-sparing” approach by several authors, as it avoids the need for a large
muscle tenotomy (i.e. gluteus medius in the lateral approach) or intra-muscular
dissection (i.e. gluteus maximus in the posterior approach) 17, 18. Cadaveric
studies have demonstrated that less muscle damage occurs during an anterior
versus posterior approach to the hip 19. This study is limited by the use of
cadaveric specimens as muscle tissue would respond differently in-vivo,
particularly during soft tissue retraction to facilitate surgical exposure. Patients
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have reported that minimizing muscle damage during surgery would be a
reason to choose a particular surgical approach over another 20.
Psychologically, this may motivate patients to get up and mobilize sooner.
Knowing that they have less muscle damage to protect during daily activities
may expedite functional improvement detected on clinical outcome measures.
Pain reduction following a THA performed through an anterior approach is
another possible reason for earlier functional recovery. Goebel et al. studied
pain perception, narcotic consumption, and length of stay in hospital in an
anterior versus lateral THA cohort. They found that the anterior cohort reported
significantly less post-operative pain on a visual analogue scale and less
narcotic consumption following chart review, and shorter hospital stays 21.
However, our study demonstrated no difference in composite pain scores
across all of the clinical outcome measures.
Another explanation for the difference may be related to the incidence of
abductor tendon degeneration and atrophy following a THA through a lateral
approach. Bremer et al. examined the abductor complex using MRI following
THA and found a higher incidence of abductor tendinosis and gluteus medius
muscle atrophy in patients having a lateral versus anterior approach at one-year
post-operatively 22. Abductor insufficiency can cause functional limitations and
increased pain post-operatively 23, 24. It is likely that the abductor insufficiency
complicates certain functional activities (i.e. ascending and descending stairs),
thus the discrepancy is reflected in early (6-week) functional scores rather than
pain scores. This may explain why the posterior approach, which spares the
abductor complex, also outperformed the lateral approach on a functional
composite score. It is also important to note that 20% of patients with hip
osteoarthritis may have abductor insufficiency at the time of THA 25, however,
all cohorts performed similarly across pain and functional composite scores preoperatively in our study. Finally, there were no significant differences at 3-
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months, which may be because 3-months is the usual duration of musculotendinous healing 26, or patients have learned to adapt to functional limitations.
There were significantly more complications in the anterior approach cohort
throughout the study. The incidence of 17.5% for lateral femoral cutaneous
nerve palsies falls within ranges reported in the literature 27. The high number of
nerve palsies is likely due to the nerve’s variable course around the anterior
superior iliac spine during superficial dissection, resulting in iatrogenic injury, or
during rigorous soft tissue retraction required during femoral or acetabular
exposure, resulting in a tension neuropraxia 17. Our study suggests that
although injury to lateral femoral cutaneous nerve is common with an anterior
approach, it has no detrimental effect on pain or function following a THA. As
well, caution needs to be exercised when using a specialized table for the
anterior approach. Two complications (an ankle and knee sprain) occurred as a
direct result of limb manipulation using this table, which have also been
described by other authors well versed in using the anterior approach 17.
Our study is not without limitations. It is difficult to perform a randomized,
controlled trial using surgical procedures as the intervention. It would not of
been ethical to randomize patients to one of the three approaches after they
had established rapport with their assigned surgeon. This does introduce
selection bias into the study design; fortunately, our groups were relatively
homogeneous. This would require a multi-centre, multi-surgeon study where all
surgeons were proficient in all three surgical approaches. Loss to follow-up is
an obvious limitation, increasing the chance of a type II error, especially with a
small sample size. However, we did account for 10% loss in our sample size
calculation, which allowed for adequate numbers in the anterior and lateral
groups at all time points. Every effort was taken to find out the reason for the
missed appointment in order to complete the data. Once all patients have
completed the required follow-up, imputation of mean values or regression will
be used to complete missing data. The follow-up period was also relatively
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short. However, as discussed earlier, the purported functional advantages of
the anterior approach occur in the first 6-weeks to 3-months in many studies,
thus we felt this was a long enough time duration to satisfy our hypothesis.
Lastly, the external validity of the study is limited by each approach being
performed by a single surgeon from a single institution. This also introduces
performance bias as some surgeons are more proficient at certain procedures
than others; however, our study was designed to optimize internal validity.
Our study has several strengths. Perhaps the most important was that every
patient in this study received standardized implants (see Appendix D). Femoral
stem design, femoral and acetabular fixation (cementless versus cemented),
and bearing surfaces can all influence clinical outcomes. For instance,
cylindrical, extensively porous-coated femoral stems are known to cause an
increased incidence of anterior thigh pain, which can then influence pain
composite scores on various outcome measures 28, 29. To our knowledge,
standardization of all components has not been described in any other study
examining the effects of surgical approach on THA outcomes. We also chose to
use validated disease-specific and generic clinical outcome measures. This
allowed us to gauge not only the effect of the intervention in mitigating pain and
dysfunction associated with hip arthritis, but also the effect of the disease
process and intervention on emotional and mental health.
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3.5 Conclusion
This study examined the effect of surgical approach in THA on validated,
disease-specific and generic clinical outcome measures using standardized
implants. The anterior approach demonstrated superior functional outcomes at
6-weeks when compared to the lateral approach, but not the posterior
approach. Complication rates, specifically lateral femoral nerve palsies, were
significantly higher in the anterior approach group. Further research directions
include using imaging modalities such as MRI to diagnose muscle damage and
tendinosis following THA, and correlating these findings with changes seen in
daily activities such as gait analysis. As well, the impact of surgical approach on
component positioning and revision rates was not addressed in this study, but is
an area of interest. All three surgical approaches produce positive changes that
exceed the minimally important difference across various clinical outcome
measures.
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Chapter 4
4

Surgical approach in total hip arthroplasty: A costanalysis

4.1 Introduction
Total hip arthroplasty (THA) is a commonly performed surgical procedure for
the treatment of hip arthritis. Approximately 50,000 THAs are performed on an
annual basis in Canada 1. The costs incurred to the healthcare system are
tremendous, amounting to anywhere between 4.3 and 7.3 billion dollars each
year (1994 Canadian dollars) 2. Despite the substantial financial burden of THA
on healthcare economics in Canada, few studies have provided accurate cost
estimations of this procedure 2, 3.
Total hip arthroplasty has been the subject of cost-analysis studies. When
comparing the procedure to non-operative treatment of hip osteoarthritis, THA
is cost-effective, and in some instances, cost-saving 4. Other studies have
examined the impact of different bearing articulations, stem designs, and
fixation methods on cost-effectiveness in THA 5-7. However, these studies have
relied on retrospective analyses of costs, and the perspective of the analyses
has been unclear. Also, the impact of surgical approach on costs following THA
has not been fully elucidated.
The purpose of this study was to determine the impact of surgical approach on
costs in THA. This prospectively designed study will provide an accurate
representation of costs following this intervention from a Canadian institution.
Our hypothesis was that surgical approach would not result in significant
differences in costs in patients undergoing THA.
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4.2 Materials and Methods
4.2.1 Study framework
Institutional review board ethics approval was attained at Western University.
Patients were recruited as per the patient enrolment and selection protocol
outlined in Chapter 3. All patients were recruited from a single institution
through University Hospital at Western University. A total of 118 patients were
recruited to partake in the study. Patients were followed prospectively in order
to provide accurate assessments of cost in patients undergoing a THA through
either an anterior, posterior, or lateral approach. Each procedure was
performed as outlined in Chapter 3, with all patients receiving standardized
implants.

4.2.2 Study perspective
The goal of this study is to determine the impact of surgical approach on total
costs for THA from a hospital, or ministry of health, perspective.

4.2.3 Boundaries of the analysis
This study’s goal was to provide a cost-analysis that would impact clinical
practice in both academic and community settings in Canada. Therefore, the
inclusion and exclusion criteria (Table 3.1) were thought to represent the most
common patient population undergoing a THA. Only THAs performed through
either an anterior, posterior, or lateral approach were included.

4.2.4 Time horizon for the study
The time horizon for the cost-analysis included the time of admission to hospital
to time of discharge from hospital following the procedure. The official time to
admission and discharge was extracted from each patient’s electronic medical
record.
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4.2.5 Determining costs
All costs throughout this study were acquired prospectively. A micro-costing
method was used to determine all costs throughout the study. Dollar values are
disseminated in 2013 Canadian dollars.

4.2.5.1

Operating room costs

The cost of the operating room time was calculated from the moment the
patient entered the room, to the time they left the room to recover in the postanesthetic care unit (PACU). A per minute direct and indirect operating room
cost was acquired from the costing department at London Health Sciences
Centre (LHSC). Costs applicable to the billing surgeon and anesthetist were
acquired through the Ontario Ministry of Health’s schedule of benefits 8. The
Inventory Control Clerk for LHSC provided the cost of implants and operating
room supplies such as drapes and sutures.
There were some items that were utilized specifically for the anterior approach.
Intra-operative fluoroscopy was monetized on a per minute basis, capturing the
direct and indirect costs of the technician and use of the C-arm fluoroscopic
machine. The cost of the radiologist reading the film post-operatively was
acquired from the Ontario Ministry of Health’s schedule of benefits 8. Lead
aprons were required during all anterior approach procedures in order to protect
against fluoroscopic radiation. The cost of each lead apron was distributed on a
per case basis using 1-year as the longevity of the item. At least seven
personnel would require an apron during each case: surgeon, surgical assistant
/ clinical fellow, resident / medical student, anesthesia consultant, scrub nurse,
circulating nurse, and x-ray technician. Approximately 130 anterior approach
THAs are performed annually, resulting in the following calculation:
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$700 per apron x 7 personnel = $4900 per year on aprons
$4900 per year / 130 anterior cases per year = $37.70 per case
The traction table (Hana TM fracture table, Mizuho OSI, Union City, CA) was also
incorporated into the final cost. The longevity of the table is 5-years as
recommended by the manufacturer, resulting in the following calculation:
$120,000 per table / 5-year longevity = $24,000 per year
$24,000 per year / 130 anterior cases per year = $185 per case
Appendix E outlines an example of all of the costs captured during each
operating room visit.

4.2.5.2

In-hospital costs

Following each operation, the patient would then be admitted to the PACU.
Patient care and resource utilization costs in the PACU were represented on a
per minute basis in consultation with the LHSC costing department. The length
of each PACU admission was determined as the time leaving the operating
room, to the time of admission to the inpatient ward. This information was
gathered from paper and electronic chart review.
Following discharge from the PACU, the patient is admitted to the inpatient
orthopedic ward. All patients received 24 hours of post-operative antibiotics, as
well as deep vein thrombosis prophylaxis. Nursing care costs were based on an
average per hour wage at LHSC. Administered medications, care items (i.e.
dressing changes, urinary catheterizations), and investigations performed were
recorded from paper and electronic chart review prospectively throughout each
patient’s admission using an In-hospital Stay Data Collection Sheet (see
Appendix C). These costs were acquired from the costing department and
pharmacy at LHSC. The Ministry of Health’s schedule of benefits was used to
determine costs for consultations from other physicians (i.e. acute pain
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services, internal medicine, infectious diseases, radiology). Allied health
resources such as physiotherapy, occupational therapy, and social work were
assigned a per-hour cost based on information from the costing department at
LHSC. The time allotted for each allied health assessment was retrieved from
paper chart review.
The total length of stay in hospital, including time in the operating room, was
recorded from the patient’s electronic chart. The in-hospital costs represented
the sum of time spent in day surgery pre-operatively, time spent in PACU, plus
time on the inpatient orthopedic ward. Appendix F provides a summary of the
information captured during each hospital stay.

4.2.6 Statistical analysis
The association between the anterior, posterior, and lateral approaches and
categorical data were evaluated by means of a nonparametric Pearson Chisquare. A one-way analysis of variance (ANOVA) was performed for continuous
demographic variables such as age and body mass index (BMI).
A one-way ANOVA was used to compare various hospital metrics and cost data
across the 3 surgical approaches, including operating room time, operating
room costs, in-hospital costs, hospital length of stay, and total costs of the
procedure. Post-hoc analysis was performed using the Scheffé test to
determine significant differences between the groups when necessary.
Statistical significance was set at p<0.05. The SPSS® v.22 (SPSS Inc.,
Chicago, IL, USA) was used for all analyses.
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4.3 Results
4.3.1 Patient demographics
Figure 4.1 is a flow diagram outlining patient recruitment, exclusions, and
completeness of intra-operative and in-hospital stay data. All 118 patients
currently participating in the study had complete intra-operative and in-hospital
data. Table 4.1 demonstrates patient demographics, including descriptive
statistics for continuous variables. There were no statistically differences
between the groups with regards to age and BMI following a one-way ANOVA.
Sex, operative side, and primary diagnosis distributions were also not
statistically different following Pearson Chi-square analysis.
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178 Patients Assigned to 3 Approaches

60 Patients Excluded:
- BMI > 40 kg/m2 = 7
- Acetabular dysplasia / DDH = 7
- Unable to walk unassisted for TUG = 7
- Inflammatory arthropathy = 6
- Post-traumatic arthritis = 5
- Previous hip surgery = 5
- Cognitively impaired = 4
- Non-English speaking = 4
- Declined participation = 4
- Different implants used = 3
- Simultaneous THA = 2
- Other: 6

Anterior Approach = 40

Lateral Approach = 40

Posterior Approach = 38
Completed data:
- Intra-operative: 40
- In-hospital: 40

Completed data:
- Intra-operative: 40
- In-hospital: 40

Completed data:
- Intra-operative: 38
- In-hospital: 38

Figure 4.1 – Flow diagram for study
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Demographic

Anterior Approach

Posterior Approach

Lateral Approach

Age (years)

Mean = 66.9
Std. Dev. = 9.5
Range = 42 - 86
Female = 25
Male = 15
Mean = 27.9
Std. Dev. = 4.3
Range = 20.8 – 36.4
Left = 22
Right = 18
Osteoarthritis = 37
Avascular Necrosis = 3

Mean = 66.7
Std. Dev. = 9.2
Range = 44 - 84
Female = 24
Male = 14
Mean = 28.2
Std. Dev. = 5.3
Range = 16.2 – 39.9
Left = 18
Right = 20
Osteoarthritis = 33
Avascular Necrosis = 5

Mean = 65.5
Std. Dev. = 10.4
Range = 42 – 92
Female = 26
Male = 14
Mean = 29.1
Std. Dev. = 5.6
Range = 19.9 – 39.9
Left = 18
Right = 22
Osteoarthritis = 38
Avascular Necrosis = 2

Sex
Body Mass
2
Index (kg/m )
Operative
Side
Primary
Diagnosis

Table 4.1 – Patient demographics
Sample demographics with means, standard deviations, and ranges for
continuous variables.
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pvalue
0.792

0.971
0.541

0.647
0.418

4.3.2 Intra-operative time and costs
The 3-group comparison for procedure time (time from cutting skin to wound
closure) and total time in the operating room (time in room to time out of room)
can be found in Figure 4.2. Descriptive statistics for procedure time, total time in
the operating room, and time to position each patient in preparation for each
procedure are included in Table 4.2.
One-way ANOVA testing revealed statistically significant differences between
the groups for procedure time, total time in the operating room, and patient
positioning time. Post-hoc testing demonstrated significantly shorter procedure
time for the lateral versus anterior and posterior approach (p=<0.001 and
p<0.001, respectively). The procedure time was also significantly shorter for the
posterior versus anterior approach (p=0.005). Total time in the operating room
was significantly shorter for the lateral versus anterior and posterior approach
(p<0.001 and p=0.008, respectively). Positioning time was significantly shorter
for the anterior versus posterior approach (p=0.001).
Intra-operative costs are disseminated in 2013 Canadian dollars for both the
cost of the operating room time only (Figure 4.3), as well as the total procedural
cost (Figure 4.4 and Table 4.3). A detailed breakdown of the costs acquired can
be found in the Appendix C. One-way ANOVA testing revealed statistically
significant differences between the groups for both operating room time costs
and total procedural costs. Post-hoc testing determined that the cost of the
operating room time was significantly less for the lateral versus anterior and
posterior approach (p<0.001 and p=0.008, respectively). The total cost of the
procedure was significantly less for the lateral versus anterior and posterior
approach (p<0.001 and p=0.001, respectively), and the posterior versus
anterior approach (p=0.008).
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Surgical Approach and Operating
Room Time
120
100

Time (min)

80
60
40
20
0
Anterior

Posterior

Lateral

Mean Procedure Time

Anterior

Posterior

Lateral

Mean Total Time in OR

Figure 4.2 – Procedure time and total operating room time
Mean procedure time and total operating room times for each surgical
approach. Error bars represent 95% confidence intervals. Pair
Pair-wise
wise
comparisons with statistical significance are denoted by symbols.
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Procedure time
(min)
Total time in
OR (min)
Patient
positioning
time (min)

Anterior
Approach
(mean +/- SD)
69.3 +/- 10.1

Posterior
Approach
(mean +/- SD)
61.6 +/- 11.9

Lateral
Approach
(mean +/- SD)
49.0 +/- 8.1

p-value

105.7 +/- 11.8

99.6 +/- 17.9

87.7 +/- 18.8

<0.001

11.2 +/- 3.8

15.1 +/- 5.5

12.9 +/- 4.2

0.001

<0.001

Table 4.2 – Descriptive statistics for intra-operative times
Descriptive statistics including means and standard deviations are outlined in
the table, as well as the p-values for the one-way, between-group ANOVA for
various operating room metrics.
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Cost of Operating Room Time
2000

Mean Cost (2013 Canadian Dollars)

1800
1600
1400
1200
1000
800
600
400
200
0
Anterior

Posterior
Surgical Approach

Lateral

Figure 4.3 – Cost of operating room time
Mean cost of operating room time for each surgical approach. Error bars
represent 95% confidence intervals. Pair
Pair-wise
wise comparisons with statistical
significance are denoted by symbols
symbols.
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Total Cost of Procedure

Mean Cost (2013 Canadian Dollars)

6000

5000

4000

3000

2000

1000

0
Anterior

Posterior
Surgical Approach

Lateral

Figure 4.4 – Total procedural cost
Mean cost of the entire intra
intra-operative
operative procedure for each surgical approach.
Error bars represent 95% confidence intervals. Pair-wise
wise comparisons with
statistical significance are denoted by symbols
symbols.
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Cost of
operating
room time
(2013
Canadian
dollars)
Total cost
of
procedure
(2013
Canadian
dollars)

Anterior Approach
(mean +/- SD)

Posterior Approach
(mean +/- SD)

Lateral Approach
(mean +/- SD)

pvalue

$1729.90 +/- 193.10

$1629.92 +/- 292.82

$1435.24 +/- 307.70

<0.001

Range: $1407.82 –
2062.62

Range: $1145.90 –
2553.72

Range: $965.83 –
2259.06

$5799.79 +/- 254.12

$5560.24 +/- 362.36

$5274.39 +/- 362.22

Range: $5412.19 –
6432.15

Range: $4959.43 –
6577.39

Range: $4735.21 –
6223.16

<0.001

Table 4.3 – Descriptive statistics for operating room costs
Descriptive statistics including means, standard deviations, and ranges are
outlined in the table, as well as the p-values for the one-way, between-group
ANOVA for operating room and procedural costs.

147

4.3.3 Hospital length of stay and costs
The 3-group comparison for hospital length of stay, as well as associated
inpatient costs, can be found in Figures 4.5 and 4.6 and Table 4.4. One-way
ANOVA testing demonstrated statistically significant group differences for
hospital length of stay and total inpatient costs. Post-hoc testing revealed a
statistically significant shorter length of stay for the anterior versus posterior and
lateral approach (p<0.001 for both pair-wise comparisons). Length of stay was
comparable between the posterior and lateral approach (p=0.952). The total
inpatient costs were significantly less for the anterior versus lateral and
posterior approach (p<0.001 for both pair-wise comparisons). Total inpatient
costs were comparable between the posterior and lateral approach (p=0.729).
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Hospital Length of Stay

80

70

Mean hours (h)

60

50

40

30

20

10

0
Anterior

Posterior
Surgical Approach

Lateral

Figure 4.5 – Hospital length of stay
Mean hospital length of stay for each surgical approach. Error bars represent
95% confidence intervals. Pair
Pair-wise
wise comparisons with statistical significance
are denoted by symbols
symbols.
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Inpatient Hospital Costs
3500

Mean Cost (2013 Canadian Dollars)

3000

2500

2000

1500

1000

500

0
Anterior

Posterior
Surgical Approach

Lateral

Figure 4.6 – Total inpatient hospital costs
Mean total inpatient costs for each surgical approach. Error bars represent 95%
confidence intervals. Pair
Pair-wise comparisons with statistical significance
nificance are
denoted by symbols.
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Hospital
length of
stay
(hours)
Total cost
of
inpatient
stay (2013
Canadian
dollars)

Anterior Approach
(mean +/- SD)

Posterior Approach
(mean +/- SD)

Lateral Approach
(mean +/- SD)

pvalue

33.9 +/- 13.4

65.8 +/- 27.2

64.2 +/- 23.5

<0.001

Range: 24.9 – 98.4

Range: 29.1 – 171.4

Range: 30.5 – 144.8

$1500.43 +/- 683.59

$2727.22 +/- 998.28

$2578.71 +/- 751.38

Range: $1099.06 –
4994.27

Range: $1255.88 –
5865.66

Range: $1625.95 +/5008.66

<0.001

Table 4.4 – Descriptive statistics for length of stay and total
inpatient costs
Descriptive statistics including means, standard deviations, and ranges are
outlined in the table, as well as the p-values for the one-way, between-group
ANOVA for hospital length of stay and total inpatient costs.
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4.3.4 Total cost of total hip arthroplasty
Figure 4.7 and Table 4.5 outline the total costs of a THA from a hospital
perspective. One-way ANOVA testing revealed statistically significant
differences between the 3 surgical approaches for total THA costs. The anterior
approach cost significantly less than both the posterior and lateral approach
following post-hoc testing (p<0.001 and p=0.031, respectively). The difference
in costs between the lateral and posterior approach was not significant
(p=0.124).
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Total Cost of THA
10000

Mean Cost (2013 Canadian Dollars)

9000
8000
7000
6000
5000
4000
3000
2000
1000
0
Anterior

Posterior
Surgical Approach

Lateral

Figure 4.7 – Total cost of THA from hospital perspective
Mean total costs of THA for each surgical approach from a hospital perspective.
Error bars represent 95% confidence intervals. Pair
Pair-wise
wise comparisons with
statistical significance are denoted by symbols.

Total cost
of THA
(2013
Canadian
dollars)

Anterior Approach
(mean +/
+/- SD)

Posterior Approach
(mean +/- SD)

Lateral Approach
(mean +/+/ SD)

pvalue

$7300.22 +/
+/- 737.08

$8287.46 +/- 1142.85

$7853.10
7853.10 +/+/ 862.41

<0.001

Range: $6657.86 –
10677.25

Range: $6797.83 –
12443.05

Range: $6587.21 –
10206.72

Table 4.5 – Descriptive statistics for total cost of THA
Descriptive statistics including means, standard deviations, and ranges are
outlined in the table, as well as the p
p-values for the one-way,
way, between-group
between
ANOVA for the total costs of a THA from a hospital perspective.
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4.4 Discussion
The purpose of this study was to determine the impact of surgical approach on
costs associated with a THA from the perspective of a hospital. A micro-costing
method was used to accurately capture costs of the procedure, as well as the
inpatient stay. There were statistically significant differences between the
groups for procedural costs, inpatient costs, and overall costs. There were also
statistically significant differences in various hospital metrics such as operating
room time and length of stay in hospital.
The total cost of a THA from a hospital perspective was significantly less when
performed using an anterior versus posterior or lateral approach. The mean
cost savings per case when compared to the lateral and posterior groups
amounts to approximately $550 to $1000, respectively. Over the course of a
calendar year, that would amount to significant cost savings to a hospital.
Some of the purported disadvantages of the anterior approach are the added
costs associated with using a specialized operating room table, such as the
Hana TM fracture table in this study, as well as costs of using intra-operative
fluoroscopy. These factors, along with prolonged mean operating room time,
contributed to increased procedural costs observed in the anterior group.
Hospital administrators may be reluctant to implement such a procedure due to
the expensive up-front costs of the specialized table ($120,000 in 2013
Canadian dollars). Increased operating room time has been reported in other
studies when comparing the anterior other surgical approaches 9, 10. Again,
administrators may find it difficult to implement this approach at the expense of
potentially completing fewer cases, or running the risk of paying hospital staff
overtime for prolonged cases.
However, a significant reduction in hospital length of stay translated into
significant cost savings overall from a hospital perspective. Several other
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studies have found that having a THA performed through an anterior approach
results in a significant reduction in days spent in hospital 9-12. This may be due
to many of the functional benefits of the anterior approach discussed in Chapter
3. Future studies should examine the effect of the earlier discharge from
hospital from a societal perspective. Patients leaving hospital earlier may
require dependence on several outpatient resources such as community care
nurses for dressing changes, outpatient physiotherapy referrals, and time
invested from alternative caregivers.
The mean costs reported in this study are higher than the previous reported
mean costs of a THA performed in Canada by Antoniou in 2004. They reported
mean costs of $6766 (2001 US dollars) from a hospital perspective, with
implant costs contributing $1695 3. Interestingly, the mean length of stay was
7.2 days in that study. Unfortunately, a detailed breakdown of the costs were
not disseminated in this study, therefore it is impossible to determine whether
most of the costs were contributed through the procedure (i.e. operating room
time) or inpatient stay in hospital. All of the implants were standardized in the
current study, amounting to $2450 (2013 Canadian dollars) per case. It is clear
from the micro-costing method utilized in this study that most of the overall
costs are contributed by the total cost of the procedure.
Therefore, in order to reduce costs, hospital administrators need to look at
either improving operating room efficiency or reducing the number of days
patients spend in hospital. Examining the data closely, approximately 40
minutes were spent in the operating room not operating on patients. This time
would include time to administer and reverse the anesthetic, and patient
positioning. Literature suggests that dedicated operating room units (i.e.
anesthesia and nursing staff facile in a certain procedure) can reduce operating
room time and patient turnover 13. Time spent waiting in the operating room due
to patient turnover incurs tremendous costs, as the per minute rate for the
operating room is substantially higher than that of the post-anesthetic care unit
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or orthopedic ward. Another factor to consider is day of surgery, as well as time
of day when the surgery is performed. Surgery performed later in the day or on
Fridays could reduce exposure to physiotherapy due to resource limitations.
Dedicated rehabilitation protocols for specific procedures such as THA have
been shown reduce length of stay 14. Finally, procedures that permit earlier
functional independence and reduce post-operative pain, such as the anterior
approach for THA, can reduce hospital length of stay 12, 15.
The generalizability of the data is a limitation of this study. The cost data is
taken from a single academic institution within a publically funded healthcare
system, which would undoubtedly vary from one hospital to another and one
healthcare model to another. As well, the anterior approach can be performed
without the use of a specialized table or intra-operative fluoroscopy, which may
have reduced costs even further 16. Furthermore, a single surgeon from a single
academic institution performed each surgical approach. Undoubtedly, other
surgeons may use different instrumentation (i.e. the traction table for the
anterior approach), or approach the hip differently than the steps outlined in our
study. Another limitation is that the cost data is also presented using a small
sample of patients with hip arthritis. Operating room time and length of stay in
hospital may vary for other primary diagnoses, such as inflammatory
arthropathy, post-traumatic arthritis, or developmental dysplasia of the hip.
Finally, physiotherapy assessments and treatment was unblinded. This could
have introduced expectation bias, thus influencing length of stay in hospital.
However, weight-bearing status and discharge milestones were standardized
as per our institution’s discharge pathway.
Our study has several strengths. To our knowledge, this is the first study
examining the impact surgical approach has on costs associated with THA. The
prospective, micro-costing method ensured that cost data was captured
accurately. Our hopes are that this study can then stand as a reference for
gross-costing analyses in future cost-effectiveness analyses. Standardizing the
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implants, and thus standardizing the cost of the implants, eliminated the
tremendous variability in implant costs from influencing the results 17. Other
institutions can then infer the impact on implant costs on their overall costs,
assuming the other variables (operating room and inpatient costs) are similar.
The detailed analysis regarding intra-operative time and inpatient length of stay
will help decision makers determine where they can invest resources in order to
improve cost-savings within their own institution.
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4.5 Conclusion
This study examined the impact of surgical approach on costs in patients
undergoing THA. The anterior approach group demonstrated significantly
reduced overall costs compared to a lateral and posterior approach cohort. The
cost-savings were largely amassed through a significant reduction in hospital
length of stay. The micro-costing method provided an accurate estimation of
THA costs from within a Canadian institution. Future studies should examine
the impact of surgical approach on outpatient costs from a societal perspective,
and combine effectiveness measures in a formal cost-effectiveness analysis.
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Chapter 5
5

General discussion and conclusions

The choice of surgical approach for total hip arthroplasty (THA) is an area of
debate amongst orthopaedic surgeons. The distribution of surgical approach
used for THA varies not only in Canada, but internationally 1, 2. Several studies
have sought to elicit the impact of surgical approach on clinical outcomes in
THA with mixed methodologies. There is also a paucity of literature examining
any financial implications of utilizing a particular surgical approach for THA from
a hospital perspective. Thus, the objectives of this thesis were:
1. To compare various disease-specific and generic clinical outcome
measures across the three commonest surgical approaches for THA.
2. To explore the impact of surgical approach on costs for THA.
Accordingly, our hypotheses were:
1. There will be no significant differences between the approaches across
various clinical outcome measures at short-term follow-up.
2. There will be no significant differences in total costs from a hospital
perspective dependent on which surgical approach was used for THA.
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5.1 Surgical approach in total hip arthroplasty: The impact
on short-term patient outcomes (Chapter 3)
This study examined the effect of surgical approach on a series of validated
disease-specific and generic clinical outcome measures. We hypothesized that
there would be no differences between the surgical approach at short-term
follow-up. The results of the study rejected the hypothesis for the functional
score of the Western Ontario and McMaster Osteoarthritis Index (WOMAC)
questionnaire, and the usual activities dimension of the EQ-5D, at 6-weeks
follow-up. The posterior approach also outperformed the lateral approach on
the functional composite score of the Harris hip score (HHS). All other clinical
outcome comparisons did not demonstrate statistical significance.
Several theories exist as to why the anterior approach may provide an earlier
functional benefit over other surgical approaches. Commonly cited reasons
include “muscle-sparing” intervals and reduced post-operative pain 3-6.
However, cadaveric studies have demonstrated that muscle damage is
sustained during an anterior approach 7. Additionally, our study did not
demonstrate any significant differences in the pain composite scores across
any of the outcome measures. It may be that the abductor tenotomy performed
during a lateral approach produces enough abductor dysfunction to complicate
some functional activities in the early post-operative course. This may explain
why the posterior approach, which spares the abductor complex, outperformed
the lateral approach on a functional composite score. In the future, dynamic
kinematic studies can be used to demonstrate biomechanical differences during
routine daily activities such as stairs and gait.
Attention needs to be given to the significantly higher complication rate
observed in the anterior approach cohort. Injury to the lateral femoral cutaneous
nerve resulted in symptomatic paresthesias in 17.5% of patients undergoing a
THA through an anterior approach. Fortunately, injury to the nerve seemingly
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has no impact on clinical outcome scores following THA. This is likely because
of the nerve’s purely sensory innervation, resulting in no motor deficits and
functional compromise following injury, and that the disease-specific outcome
measures do not address nervous paresthesias in any of their questions.
However, it is important that patients are made aware of this potential
complication during informed consent, as complication rates of 17.5% are
usually unacceptably high.
This prospective study demonstrated that there are clinical differences across
the 3 main surgical approaches for THA. To our knowledge, it is the first study
comparing these 3 approaches using standardized implants, the importance of
which cannot be understated.

163

5.2 Surgical approach in total hip arthroplasty: A costanalysis (Chapter 4)
This study examined the impact of surgical approach on costs for THA from a
hospital perspective. To our knowledge, this is the first study of its kind
performing a cost-analysis on surgical approach in THA. Previous costanalyses from Canadian institutions used retrospective, database data to
acquire costs for THA 8. The prospective, micro-costing method used in this
study provided accurate data that will prove useful in future cost-effectiveness
analyses.
We were able to reject the hypothesis that there would be no cost differences
between the 3 surgical approaches following THA. The anterior approach
demonstrated significantly reduced overall costs from a hospital perspective.
Despite increased procedural costs, the anterior approach reduces overall costs
by significantly shortening hospital length of stay.
In order to reduce costs associated with operative procedures, hospital
administrators should examine the operating room and hospital stay as two
separate entities. The majority of the overall costs were incurred through the
cost of the procedure. Improving operating room efficiency through the use of
designated operating room units has been suggested 9. Surgical and anesthetic
expertise, competent support staff, and reducing patient turnover are all
principles of this concept. The use of accelerated rehabilitation protocols and
having adequate outpatient resources to support earlier hospital discharges are
important considerations 10.
The use of a labour-intense, micro-costing method has provided accurate cost
data comparing surgical approach for THA. Although the generalizability of the
data can be questioned, the principles of cost reduction remain the same, as
variables such as operating room time and length of stay in hospital are
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universal. Future directions include capturing outpatient cost data with longterm effectiveness measures (i.e. quality-adjusted life years) in order to perform
a cost-effectiveness analysis from a societal perspective.
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5.3 Conclusions
Total hip arthroplasty continues to be the cornerstone treatment modality for
painful and functionally debilitating hip arthritis. The procedure produces
tremendous clinically important differences in patient reported pain, function,
and mental health, regardless of surgical approach. The choice of surgical
approach can have a significant impact on patient reported functional
outcomes, and costs from a hospital perspective.
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Appendix A: Glossary of terms
Abduction

Movement away from the center of the body

Abductor insufficiency

Weak abductor muscles around the hip causing
either pain or changes in function and gait

Adduction

Movement towards the center of the body

Anteversion

Anatomic reference to something that is directed
forward, or anteriorly

Arthropathy

Any condition causing articular cartilage damage
resulting in joint arthritis

Arthroplasty

A surgical procedure where the articular surface of a
joint is replaced by some other tissue or substance

Articulation

Contact made between two surfaces covered by
articular cartilage

Capsulotomy

Incising through a joint capsule

Coronal

A vertical plane dividing the body into a front and
back section

Cost-analysis

Determining the costs and financial risks and
benefits of undergoing an intervention or procedure

Distal

Spatial relationship away from the trunk of the body
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Extension

A straightening motion between two body parts that
increases an angle formed by those two parts

External rotation

Rotation away from the center of the body

Flexion

A bending motion between two body parts that
decreases an angle formed by those two parts

Fluoroscopy

The use of x-rays during a procedure

Idiopathic

Unknown pathogenesis of a disease process

Insertion

The more distal attachment site of a muscle or
ligament

Internal rotation

Rotation towards the center of the body

Interval

In surgery, refers to a plane between the fascia of
two different muscles, typically innervated by
different nerves

Lateral

Away from the body’s midline

Lateral decubitus

Patient position during surgery when they lie on their
side

Medial

Closer to the body’s midline

Micro-costing

A method of acquiring costs of health resources that
involves attaching an exact cost to a resource
consumed during an intervention
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Muscle-sparing

Surgery that involves minimal dissection of muscular
tissue

Neuropraxia

Injury to a nerve resulting in temporary loss of
sensation or motor function supplied by that nerve

Origin

The more proximal attachment site of a muscle or
ligament

Osteophytosis

Formation of osteophytes, or irregular bony
prominences, as a consequence of arthritis

Osteotomy

Surgical cutting or removal of bone

Paresthesia

Sensory change, often describes as tingling or “pinsand-needles”, in the distribution of a nerve due to
injury or degeneration

Perspective

The targeted audience of a cost-analysis

Peri-prosthetic

Occurring around a prosthesis used during a joint
replacement

Proximal

Spatial relationship towards the trunk of the body

Retroversion

Anatomical reference to something that is directed
backward, or posteriorly

Sagittal

A vertical plane dividing the body into a right and left
half
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Subchondral cyst

A fluid-filled sac underlying a joint surface due to
arthritis

Subchondral sclerosis

Thickening and hardening of the bone underlying
articular cartilage due to arthritis

Surgical approach

Soft tissue dissection and working between internervous or inter-muscular planes in order to reach a
specific anatomic location (i.e. the hip joint)

Synovial joint

Articulation between two bones covered by articular
cartilage and encapsulated by a joint capsule filled
with synovial fluid

Tenotomy

Incising through or releasing a tendon from its
insertion

Transverse

A horizontal plane dividing the body into an upper
and lower section

Trendelenburg gait/sign

A gait pattern / physical exam finding due to weak
abductor muscles where the center of gravity is
shifted away from the affected leg to reduce load on
the abductor muscles
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Appendix B: Abbreviations list
ACR

American College of Rheumatology

ANOVA

Analysis of variance

BL

Brent Lanting

BMI

Body mass index

CK

Creatine kinase

CRP

C-reactive protein

ESR

Erythrocyte sedimentation rate

EV

Edward Vasarhelyi

FAI

Femoroacetabular impingement

HHS

Harris hip score

ICER

Incremental cost-effectiveness ratio

JH

James Howard

LHSC

London Health Sciences Centre

MCS

Mental component summary

MID

Minimally important difference
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MRI

Magnetic resonance imaging

NSAID

Non-steroidal anti-inflammatory drug

PACU

Post-anesthetic care unit

PCS

Physical component summary

QALY

Quality-adjusted life year

RCT

Randomized-controlled trial

SDC

Smallest detectable change

SEM

Standard error of measurement

SF-12

Short-form 12 questionnaire

THA

Total hip arthroplasty

TUG

Timed up-and-go test

US

United States

VAS

Visual analogue scale

WOMAC

Western Ontario and McMaster Osteoarthritis Index
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Appendix C: In-hospital Stay Data Collection Sheet
Surgical approach in total hip arthroplasty: Patient outcomes and impact
on costs
In-hospital Stay Data Collection Sheet
Patient PIN:
Surgeon:

JH



EV



BL



Date of Surgery (DD/MM/YYYY):
Date and Time of Admission
(DD/MM/YYYY, HH:MM):
Date and Time of Discharge
(DD/MM/YYYY, HH:MM):
Hospital Investigations:
Investigation

Number of
Tests

Date of Test (i.e. POD
1, 2, 3, etc.)

Other
Information
(i.e. +’ve/-‘ve
US, CT-PA to
r/o PE)

CBC
Lytes
BUN/Cr
Extended Lytes
Albumin
LFTs
CK/Trops
Thyroid (TSH)
Chest X-ray
Abdo X-ray
CT scan (chest, abdo, pelvis)
Lower extremity Doppler U/S
Urine R&M, C&S
ECG
Echocardiogram
Pelvis X-ray / Hip X-ray
Other:
Other:
Other:
Other:
Blood Transfusions: Yes



No



Number:

In-hospital Consultations:
Consulting Service

Date of Consult

Number of
Assessments
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Intervention (i.e.
additional surgery,

ICU admit, scope)
Internal Medicine
Acute Pain Service (APS)
Critical Care Team (CCOT)
Gastroenterology (GI)
General Surgery
Other:
Other:
Other:
Other:
Allied-health Assessments:
Consulting Service

Date of Consult

Number of
Assessments

Intervention
(i.e. fit for
walker/crutches,
home
adjustments by
OT, dressing
changes/home
PT through
CCAC, etc.)

Physiotherapy
Occupational Therapy
Social Work
CCAC
Other:
Other:
Dressing Changes:
Type of Dressing (i.e. Tegaderm, gauze)

Number of Dressing Changes

Complications:
Complication

Date of
Complication

Urinary tract infection
Deep vein thrombosis
Pulmonary embolism
Pneumonia
Wound infection
Peri-prosthetic fracture
Dislocated hip
Nerve Palsy
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Intervention (i.e. antibiotics and for how
long, surgery, medication, etc.)

Urinary Retention (i.e. foley
catheter/in-and-out)
Other:
Other:
Other:
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Appendix D: Summary of implant selection
Study
No.

Surgical
Approach
1

Anterior

Acetabular Implant

Femoral stem Implant

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard, Collared

2

Anterior

DePuy 60mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 15 Coxa Vara Lateralized

3

Anterior

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

22

Anterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

24

Anterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Coxa Vara Lateralized

27

Anterior

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

30

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

31

Anterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

32

Anterior

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

34

Anterior

DePuy 60mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 14 Coxa Vara Lateralized

35

Anterior

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Coxa Vara Lateralized

36

Anterior

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

37

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Coxa Vara Lateralized

42

Anterior

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

51

Anterior

DePuy 62mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 15 Coxa Vara Lateralized

59

Anterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

60

Anterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Coxa Vara Lateralized

68

Anterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

70

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

79

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Coxa Vara Lateralized

80

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Coxa Vara Lateralized

87

Anterior

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

88

Anterior

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Standard Collared

94

Anterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Standard Collared

95

Anterior

DePuy 60mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 14 Standard Collared

103

Anterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

104

Anterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

105

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

107

Anterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Coxa Vara Lateralized

113

Anterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Coxa Vara Lateralized

116

Anterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Standard Collared

132

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Coxa Vara Lateralized

138

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

142

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

146

Anterior

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Coxa Vara Lateralized

154

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

156

Anterior

DePuy 48mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

157

Anterior

DePuy 48mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

167

Anterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared
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Anterior

DePuy 64mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Coxa Vara Lateralized
DePuy Corail Size 13 Standard Collared

5

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

10

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Coxa Vara Lateralized

11

Posterior

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

14

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

17

Posterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

20

Posterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

33

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Coxa Vara Lateralized

41

Posterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Standard Collared

43

Posterior

DePuy 64mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

45

Posterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

46

Posterior

DePuy 60mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

48

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Standard Collared

52

Posterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

53

Posterior

DePuy 60mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Coxa Vara Lateralized

54

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

55

Posterior

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

58

Posterior

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

71

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Coxa Vara Lateralized
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75

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

76

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared
DePuy Corail Size 13 Standard Collared

98

Posterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Coxa Vara Lateralized

120

Posterior

DePuy 62mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

137

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

139

Posterior

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

147

Posterior

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Coxa Vara Lateralized

150

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

155

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Standard Collared

159

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

161

Posterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Standard Collared

162

Posterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Coxa Vara Lateralized

166

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

168

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

173

Posterior

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Coxa Vara Lateralized

176

Posterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Coxa Vara Lateralized

177

Posterior

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

178

Posterior

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

128

Posterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Coxa Vara Lateralized

129

Posterior

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

6

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

9

Lateral

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

12

Lateral

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

15

Lateral

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

19

Lateral

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Standard Collared

23

Lateral

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Standard Collared

25

Lateral

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

29

Lateral

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

38

Lateral

DePuy 64mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

47

Lateral

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Coxa Vara Lateralized

49

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

61

Lateral

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

62

Lateral

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

63

Lateral

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

64

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Standard Collared

65

Lateral

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

66

Lateral

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 9 Standard Collared

67

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

72

Lateral

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

73

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

77

Lateral

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Coxa Vara Lateralized

81

Lateral

DePuy 56mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

89

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

90

Lateral

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Standard Collared

91

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

92

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

93

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

99

Lateral

DePuy 50mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 8 Standard Collared

100

Lateral

DePuy 64mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Standard Collared

101

Lateral

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

102

Lateral

DePuy 60mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Coxa Vara Lateralized

106

Lateral

DePuy 60mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

112

Lateral

DePuy 60mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 13 Standard Collared

114

Lateral

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Coxa Vara Lateralized

117

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 12 Standard Collared

123

Lateral

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

130

Lateral

DePuy 54mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

131

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 10 Standard Collared

140

Lateral

DePuy 58mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared

144

Lateral

DePuy 52mm Pinnacle Sector II Acetabular Cup

DePuy Corail Size 11 Standard Collared
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Study
No.

Surgical
Approach

Femoral head Implant

Polyethylene Implant

1

Anterior

DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

2

Anterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

3

Anterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

22

Anterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

24

Anterior

DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

27

Anterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

30

Anterior

DePuy 32mm Pinnacle Altrx Liner

31

Anterior

DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome
DePuy 36mm, Minus 2.0 Articuleze Cobalt
Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

32

Anterior

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

34

Anterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

35

Anterior

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

36

Anterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

37

Anterior

DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

42

Anterior

DePuy 36mm Pinnacle Altrx Liner

51

Anterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome
DePuy 36mm, Minus 2.0 Articuleze Cobalt
Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

59

Anterior

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

60

Anterior

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

68

Anterior

DePuy 32mm Pinnacle Altrx Liner

70

Anterior

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome
DePuy 36mm, Minus 2.0 Articuleze Cobalt
Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

79

Anterior

DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

80

Anterior

87

Anterior

DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome
DePuy 36mm, Minus 2.0 Articuleze Cobalt
Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

88

Anterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

94

Anterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

95

Anterior

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

103

Anterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

104

Anterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

105

Anterior

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

107

Anterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner, 10 Degree

113

Anterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

116

Anterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

132

Anterior

DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

138

Anterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

142

Anterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

146

Anterior

DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

154

Anterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

156

Anterior

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

157

Anterior

DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

167

Anterior

DePuy 32mm Plus 4 Pinnacle Altrx Liner

172

Anterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome
DePuy 36mm, Minus 2.0 Articuleze Cobalt
Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

DePuy 32mm Pinnacle Altrx Liner

5

Posterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

10

Posterior

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

11

Posterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

14

Posterior

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

17

Posterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

20

Posterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 54mm Pinnacle Altrx Liner

33

Posterior

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

41

Posterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

43

Posterior

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

45

Posterior

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

46

Posterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

48

Posterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

52

Posterior

DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

53

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

54

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

55

Posterior

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

58

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

71

Posterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

75

Posterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

76

Posterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

180

98

Posterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

120

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

137

Posterior

DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

139

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

147

Posterior

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

150

Posterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

155

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

159

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

161

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

162

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

166

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

168

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

173

Posterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner, 10 Degree

176

Posterior

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

177

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

178

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

128

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

129

Posterior

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

6

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

9

Lateral

DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

12

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

15

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

19

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

23

Lateral

DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

25

Lateral

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

29

Lateral

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

38

Lateral

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

47

Lateral

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Plus 4 Pinnacle Altrx Liner

49

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

61

Lateral

DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

62

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

63

Lateral

DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

64

Lateral

DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

65

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

66

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

67

Lateral

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

72

Lateral

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

73

Lateral

DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

77

Lateral

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

81

Lateral

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

89

Lateral

DePuy 32mm, Plus 9.0 Articuleze Cobalt Chrome

DePuy 32mm Plus 4 Pinnacle Altrx Liner

90

Lateral

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

91

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

92

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

93

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

99

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner
DePuy 36mm Pinnacle Altrx Liner

100

Lateral

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

101

Lateral

DePuy 32mm, Plus 1.0, Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

102

Lateral

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

106

Lateral

DePuy 36mm, Plus 1.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

112

Lateral

DePuy 36mm, Plus 8.5 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

114

Lateral

DePuy 36mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 36mm Pinnacle Altrx Liner

117

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

123

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

130

Lateral

DePuy 32mm, plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

131

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

140

Lateral

DePuy 32mm, Plus 1.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner

144

Lateral

DePuy 32mm, Plus 5.0 Articuleze Cobalt Chrome

DePuy 32mm Pinnacle Altrx Liner
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Appendix E: Summary of intra-operative costs
Study No.

Time of Fluoroscopy (s)

Volume of irrigation per case

Surgical Approach

Cost of irrigation

Surgeon

Procedure Time (min)
Cost per min Fluoro machine and
technician

Surgery Date

Radiology Cost to read Xray

Type and Number of sutures

Operative Side

Cost of fluoroscopy

Cost of sutures

Cautery

Type of post-op dressing

Cost of cautery

Cost of dressings

Primary Diagnosis
Procedure Time (min)
Total Time in OR (min)
Direct cost per min OR

Number of blood transfusions

Tubing

Indirect cost per min OR

Cost of blood transfusion

Cost of tubing

Total cost per min OR
Total Cost OR time

Cement used? yes=1, no=0

Wraps

Cost of cement

Cost of coban wrap

Acetabular Implant

Cost of drapes

Patient Set-up Time (min)
Turnover time (min)
Type of anesthesia

Drape type
Cost of acetabular implant

Spinal ($)

Type of saw blade

Total anesthesia time

Femoral stem Implant

Time Units

Cost of femoral stem

Basic Units (THA)
Total Cost Anaesthesia

Cost of saw blade
Type of Linen

Femoral head Implant

Cost of linen

Cost of femoral head
Type of Local Anesthetic and Volume
Cost of local anesthesia

Type of sponge
Polyethylene Implant

Cost of sponge

Cost of Polyethylene
Foley catheter 1=yes, 0=no
Cost of Foley

Gloves
Other Implant (s) - screws, wires

Cost of gloves

Cost of other implants
Type of Surgical prep
Cost of prep

OHIP cost of THA
Cost per case for Hana Table
Cost per case for lead gowns
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Grand Total Cost of Procedure

Appendix F: Summary of costs acquired for in-hospital stay
Study No.

Number of blood transfusions

HbA1c tests

Approach

Cost per transfusion

Cost per test

Surgery Date

Cost of transfusions

Cost of HbA1c tests

Date of Admission, HH:MM
Date of Discharge, HH:MM

CBC tests

Abxr Tests

Length of Stay (hrs)

Cost per test

Cost per test

Total PACU time (h)

Cost of CBC

Cost of Abxr tests
CT thorax tests

Total PACU time (min)
Direct cost per min

Lyte Tests

Indirect cost per min

Cost per test

Cost per test

Total cost per min PACU

Cost of lyte tests

Cost of CT thorax tests

LFTs

CT Abdo-pelvis tests

Total Cost PACU
Total OR Time (min)

Cost per test

Cost per test

Total OR Time (h)

Cost of LFT

Cost of CT Abdo-pelvis tests

Total inpatient time (h)

BUN/Cr tests

CT hip tests

Total cost per hour

Cost per test

Cost per test

Total cost of meals

Cost of BUN/Cr tests

Cost of CT hips tests

Total Cost Inpatient Time
CK/trop tests

ECG

Number of min Physiotherapy

Cost per test

Cost per test

Cost per min Physiotherapy

Cost of CK/Trop tests

Costs of ECG

Cost of Physiotherapy
Arterial Gas tests

Bilateral US

Number of min Social Work

Cost per test

Cost per test

Cost per min Social work

Cost of Arterial gases

Cost of Bilateral US

Cost of Social work
INR/PTT tests

Knee XR

Internal Medicine (Consult, assessment)

Cost per test

Cost per test

Acute pain service (Consult, assessment)

Cost of INR/PTT tests

Cost of Knee XR

Gastroenterology (Consult, assessment)
Infectious diseases (Consult, assessment)

Albumin tests

Echo

Hematology (Consult, assessment)

Cost per test

Cost per test

Other (Consult, assessment)

Cost of albumin tests

Cost of Echo

Total cost of consultations
TSH tests

AP hip XR

Number of min OT

Cost per test

Cost per test

Cost per min OT

Cost of TSH tests

Costs of AP hip XR

Urine R/M, C/S

Unilateral U/s

Cost of OT
Cost of Urine R/M, C/s

Cost per test
Cost of unilateral US

Foley Catheter
Cost per insertion

Post op Abx

Cost of Foley Catheter

Cost per Dose

AP Pelvis

Cost of Abx

# of doses
Cost per test
Cost of AP Pelvis

DVT prophylaxis
Cost per dose

CXR tests

# of doses

Cost per test

Cost of DVT prophylaxis

Cost of CXR tests
Other costs
Ext Lyte Test
Cost per test
Cost of Ext Lyte Tests
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Grand Total Inpatient
Costs
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